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A B S T R A C T
Background
Observational studies suggest higher pregnancy rates after the hysteroscopic removal of endometrial polyps, submucous fibroids, uterine
septum or intrauterine adhesions, which are present in 10% to 15% of women seeking treatment for subfertility.
Objectives
To assess the effects of the hysteroscopic removal of endometrial polyps, submucous fibroids, uterine septum or intrauterine adhesions
suspected on ultrasound, hysterosalpingography, diagnostic hysteroscopy or any combination of thesemethods inwomenwith otherwise
unexplained subfertility or prior to intrauterine insemination (IUI), in vitro fertilisation (IVF) or intracytoplasmic sperm injection
(ICSI).
Search methods
We searched the following databases from their inception to 16 April 2018; The Cochrane Gynaecology and Fertility Group Specialised
Register, the Cochrane Central Register of Studies Online, ; MEDLINE, Embase , CINAHL , and other electronic sources of trials
including trial registers, sources of unpublished literature, and reference lists. We handsearched the American Society for Reproductive
Medicine (ASRM) conference abstracts and proceedings (from 1 January 2014 to 12 May 2018) and we contacted experts in the field.
Selection criteria
Randomised comparison between operative hysteroscopy versus control for unexplained subfertility associated with suspected major
uterine cavity abnormalities.
Randomised comparison between operative hysteroscopy versus control for suspected major uterine cavity abnormalities prior to
medically assisted reproduction.
Primary outcomes were live birth and hysteroscopy complications. Secondary outcomes were pregnancy and miscarriage.
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Data collection and analysis
Two review authors independently assessed studies for inclusion and risk of bias, and extracted data. We contacted study authors for
additional information.
Main results
Two studies met the inclusion criteria.
1. Randomised comparison between operative hysteroscopy versus control for unexplained subfertility associated with suspected major
uterine cavity abnormalities.
In women with otherwise unexplained subfertility and submucous fibroids, we were uncertain whether hysteroscopic myomectomy
improved the clinical pregnancy rate compared to expectant management (odds ratio (OR) 2.44, 95% confidence interval (CI) 0.97 to
6.17; P = 0.06, 94 women; very low-quality evidence). We are uncertain whether hysteroscopic myomectomy improves the miscarriage
rate compared to expectant management (OR 1.54, 95% CI 0.47 to 5.00; P = 0.47, 94 women; very low-quality evidence). We
found no data on live birth or hysteroscopy complication rates. We found no studies in women with endometrial polyps, intrauterine
adhesions or uterine septum for this randomised comparison.
2. Randomised comparison between operative hysteroscopy versus control for suspected major uterine cavity abnormalities prior to
medically assisted reproduction.
The hysteroscopic removal of polyps prior to IUI may have improved the clinical pregnancy rate compared to diagnostic hysteroscopy
only: if 28% of women achieved a clinical pregnancy without polyp removal, the evidence suggested that 63% of women (95% CI
45% to 89%) achieved a clinical pregnancy after the hysteroscopic removal of the endometrial polyps (OR 4.41, 95% CI 2.45 to
7.96; P < 0.00001, 204 women; low-quality evidence). We found no data on live birth, hysteroscopy complication or miscarriage rates
in women with endometrial polyps prior to IUI. We found no studies in women with submucous fibroids, intrauterine adhesions or
uterine septum prior to IUI or in women with all types of suspected uterine cavity abnormalities prior to IVF/ICSI.
Authors’ conclusions
Uncertainty remains concerning an important benefit with the hysteroscopic removal of submucous fibroids for improving the clinical
pregnancy rates in women with otherwise unexplained subfertility. The available low-quality evidence suggests that the hysteroscopic
removal of endometrial polyps suspected on ultrasound in women prior to IUI may improve the clinical pregnancy rate compared to
simple diagnostic hysteroscopy. More research is needed to measure the effectiveness of the hysteroscopic treatment of suspected major
uterine cavity abnormalities in women with unexplained subfertility or prior to IUI, IVF or ICSI.
P L A I N L A N G U A G E S U M M A R Y
Hysteroscopy for treating suspected abnormalities of the cavity of the womb in women having difficulty becoming pregnant
Review question
Cochrane authors reviewed the evidence about the effect of the hysteroscopic treatment of suspected abnormalities of the cavity of the
womb in women having difficulty becoming pregnant.
Background
Human life starts when a fertilised egg has successfully implanted in the inner layer of the cavity of the womb. It is believed that
abnormalities originating from this site, such as polyps (abnormal growth of tissue), fibroids (non-cancerous growth), septa (upside-
down, triangular-shaped piece of tissue which divides the womb) or adhesions (scar tissue that sticks the walls of the womb together),
may disturb this event. The removal of these abnormalities by doing a hysteroscopy using a very small diameter inspecting device might
therefore increase the chance of becoming pregnant either spontaneously or after specialised fertility treatment, such as insemination
or in vitro fertilisation.
Study characteristics
We found two studies. The first study compared the removal of fibroids versus no removal in 94 women wishing to become pregnant
spontaneously from January 1998 to April 2005. The second study compared the removal of polyps versus simple hysteroscopy only in
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204 women before insemination with husband’s sperm from January 2000 to February 2004. The evidence is current to April 2018.
Neither study reported funding sources.
Key results
In women with fibroids wishing to become pregnant spontaneously we were uncertain whether removal of the fibroids improved the
pregnancy or miscarriage rate compared to usual management: uncertainty remains because the number of women (94) and the number
of pregnancies (30) were too small and the quality of the evidence was very low. We found no data on live birth or complications due
to surgery. We found no studies on women with polyps, septa or adhesions.
The hysteroscopic removal of polyps prior to intrauterine insemination (IUI; a fertility treatment where sperm is placed inside a woman’s
womb to fertilise the egg) is may improve the pregnancy rate compared to not removing polyps. If 28% of women become pregnant
without surgery, the evidence suggests that about 63% of women will become pregnant following removal of polyps. We found no data
on number of live births, hysteroscopy complications or miscarriage rates prior to IUI. We retrieved no studies in women before other
fertility treatments.
More studies are needed before hysteroscopy can be proposed as a fertility-enhancing procedure in the general population of women
having difficulty becoming pregnant.
Quality of the evidence
The quality of the evidence retrieved was very low to low due to the limited number of participants and the poor design of the studies.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Operative hysteroscopy versus control in women with otherwise unexplained subfertility and suspected major uterine cavity abnormalities
Patient or population: women with submucous f ibroids and otherwise unexplained subfert ility
Settings: infert ility centre in Rome, Italy
Intervention: hysteroscopic removal of 1 submucous f ibroid ≤ 40 mm
Comparison: no surgery
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No surgery Myomectomy
Live birth No data reported.
Adverse events: hys-
teroscopy complica-
tions
No data reported.
Clinical pregnancya
Ultrasound
12 months
214 per 1000 400 per 1000
(209 to 627)
OR 2.44
(0.97 to 6.17)
94
(1 study)
⊕©©©
Very lowb,c
-
Adverse events: mis-
carriaged
Ultrasound
12 months
119 per 1000 172 per 1000
(63 to 477)
OR 1.54
(0.47 to 5.00)
94 women
(1 study)
⊕©©©
Very lowb,c
-
* The basis for the assumed risk is the control group risk of the single included study (Casini 2006). The corresponding risk (and its 95% conf idence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OR: odds rat io.
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GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aClinical pregnancy def ined by the visualisat ion of an embryo with cardiac act ivity at six to seven weeks’ gestat ional age.
bDowngraded by two levels for very serious risk of bias (unclear allocat ion concealment, high risk of select ive outcome
report ing and unclear whether there is other bias caused by imbalance in the baseline characterist ics).
cDowngraded by one level for serious imprecision (wide conf idence interval of the ef fect size est imate).
dMiscarriage was def ined by the clinical loss of an intrauterine pregnancy between the 7th and 12th weeks of gestat ion.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
Subfertility is “a disease of the reproductive system defined by
the failure to achieve a clinical pregnancy after 12 months or
more of regular unprotected sexual intercourse” according to
the International Committee for Monitoring Assisted Repro-
ductive Technology (ICMART) and the World Health Orga-
nization (WHO) revised glossary of assisted reproductive tech-
nology (Zegers-Hochschild 2017) (see: www.icmartivf.org/ivf-
glossary.html). It is estimated that 72.4 million women are sub-
fertile and that 40.5 million of these women are currently seeking
fertility treatment (Boivin 2007). Unexplained subfertility usu-
ally refers to a diagnosis (or lack of diagnosis) made in couples in
whom all the standard investigations such as tests of ovulation,
tubal patency and semen analysis are normal: it can be found in
as many as 30% to 40% of subfertile couples (Ray 2012).
The evaluation of the uterine cavity seems a basic step in the in-
vestigation of all subfertile women since the uterine cavity and its
inner layer, the endometrium, are assumed to be important for
the implantation of the human embryo, called a blastocyst. Nev-
ertheless, the complex mechanisms leading to successful implan-
tation are still poorly understood (Taylor 2008). Despite the huge
investment in research and developments of the technologies and
biology involved in medically assisted reproduction (MAR), the
maximum implantation rate per embryo transferred still remains
only 30% (Andersen 2008). The different phases of the implanta-
tion process are established by the complex interchange between
the blastocyst and the endometrium (Singh 2011).
Major uterine cavity abnormalities can be found in 10% to 15%
of women seeking treatment for subfertility; they usually consist
of the presence of excessive normal uterine tissue (Wallach 1972).
The most common acquired uterine cavity abnormality is an en-
dometrial polyp. This benign, endometrial stalk-like mass pro-
trudes into the uterine cavity and has its own vascular supply. De-
pending on the population under study and the applied diagnostic
test, endometrial polyps can be found in 1% to 41% of the subfer-
tile population (Silberstein 2006). A fibroid is an excessive growth
originating from the muscular part of the uterine cavity. Fibroids
are present in 2.4% of subfertile women without any other obvi-
ous cause of subfertility (Donnez 2002). A submucous fibroid is
located underneath the endometrium and is thought to interfere
with fertility by deforming the uterine cavity. Intrauterine adhe-
sions are fibrous tissue strings connecting parts of the uterine wall.
They are commonly caused by inflammation or iatrogenic tissue
damage (meaning involuntarily caused by a physician’s interven-
tion, for example an aspiration curettage after miscarriage) and are
present in 0.3% to 14% of subfertile women (Fatemi 2010).
A septate uterus is a congenital malformation in which the longi-
tudinal band separating the left and right Müllerian ducts, which
form the uterus in the human female foetus, has not been entirely
resorbed. A uterine septum is present in 1% to 3.6% of women
with otherwise unexplained subfertility (Saravelos 2008).
Ultrasonography (US), preferably transvaginally (TVS), is used to
screen for possible endometrium or uterine cavity abnormalities
in the work-up of subfertile women. This evaluation can be ex-
panded with hysterosalpingography (HSG), saline infusion/gel in-
stillation sonography (SIS/GIS) and diagnostic hysteroscopy. Di-
agnostic hysteroscopy is generally considered as the gold standard
procedure for the assessment of the uterine cavity since it enables
direct visualisation; moreover, treatment of intrauterine pathology
can be done in the same setting (Bettocchi 2004). Nevertheless,
even for experienced gynaecologists, the hysteroscopic diagnosis of
themajor uterine cavity abnormalities may be problematic (Kasius
2011a).
Description of the intervention
Hysteroscopy is performed for the evaluation, or for the treat-
ment of the uterine cavity, tubal ostia and endocervical canal in
women with uterine bleeding disorders, Müllerian tract anoma-
lies, retained intrauterine contraceptives or other foreign bodies,
retained products of conception, desire for sterilisation, recurrent
miscarriage and subfertility. If the procedure is intended for evalu-
ating the uterine cavity only, it is called a diagnostic hysteroscopy. If
the observed pathology requires further treatment, the procedure
is called an operative hysteroscopy. In everyday practice, a diag-
nostic hysteroscopy confirming the presence of pathology will be
followed by an operative hysteroscopy in a symptomatic woman.
Hysteroscopy allows the direct visualisation of the uterine cavity
through a rigid, semi-rigid or flexible endoscope. The hysteroscope
consists of a rigid telescope with a proximal eyepiece and a distal
objective lens that may be angled at 0° to allow direct viewing or
offset at various angles to provide a fore-oblique view. Advances in
fibreoptic technology have led to the miniaturisation of the tele-
scopes without compromising the image quality. The total work-
ing diameters of modern diagnostic hysteroscopes are typically 2.5
mm to 4.0 mm. Operative hysteroscopy requires adequate visu-
alisation through a continuous fluid circulation using an inflow
and an outflow channel. The outer diameters of modern operative
hysteroscopes have been reduced to a diameter between 4.0 mm
and 5.5 mm. The sheath system contains one or two 1.6 mm to
2.0 mm working channels for the insertion of small grasping or
biopsy forceps, scissors, myoma fixation instruments, retraction
loops, morcellators (surgical instruments used to divide and re-
move tissue during endoscopic surgery) and aspiration cannulae,
or unipolar or bipolar electrodiathermy instruments.
Most diagnostic and many operative procedures can be done in a
clinic setting using local anaesthesia and fluid distension media,
while more complex procedures are generally performed as day
surgery under general anaesthesia (Clark 2005). Operative hys-
teroscopic procedures require a complex instrumentation setup,
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special training of the surgeon, and appropriate knowledge and
management of complications (Campo 1999).
Although complications from hysteroscopy are rare, they can
be potentially life threatening. One multicentre study including
13,600 diagnostic and operative hysteroscopic procedures per-
formed in 82 centres reported a complication rate of 0.28%. Di-
agnostic hysteroscopy had a significantly lower complication rate
compared to operative hysteroscopy (0.13%with diagnostic versus
0.95% with operative). The most common complication of both
types of hysteroscopy was uterine perforation (0.13% with diag-
nostic versus 0.76% with operative). Fluid intravasation occurred
almost exclusively in operative procedures (0.02%). Intrauterine
adhesiolysis was associated with the highest incidence of compli-
cations (4.5%); all of the other procedures had complication rates
of less than 1% (Jansen 2000).
How the intervention might work
It is assumed that major uterine cavity abnormalities may interfere
with factors that regulate the blastocyst-endometrium interplay,
for example hormones and cytokines, precluding the possibility of
pregnancy. Many hypotheses have been formulated in the litera-
ture of how endometrial polyps (Shokeir 2004; Silberstein 2006;
Taylor 2008; Yanaihara 2008), submucous fibroids (Pritts 2001;
Somigliana 2007; Taylor 2008), intrauterine adhesions (Yu 2008),
and uterine septum (Fedele 1996) are likely to disturb the im-
plantation of the human embryo; nevertheless, the precise mech-
anisms of action through which each one of these major uterine
cavity abnormalities affects this essential reproductive process are
poorly understood. The foetal-maternal conflict hypothesis tries
to explain how a successful pregnancy may establish itself despite
the intrinsic genomic instability of human embryos through the
specialist functions of the endometrium, in particular its capac-
ity for cyclic spontaneous decidualisation, shedding and regenera-
tion. An excellent indepth review linking basic research of human
implantation with clinical practice can be found elsewhere (Lucas
2013).
For endometrial polyps, submucous fibroids, intrauterine adhe-
sions and uterine septum, observational studies have shown a clear
improvement in the spontaneous pregnancy rate after the hystero-
scopic removal of the abnormality (Taylor 2008). Two observa-
tional studies suggested a better reproductive outcome following
hysteroscopic polypectomy in women prior to intrauterine insem-
ination (IUI) (Kalampokas 2012; Shohayeb 2011). The chance for
pregnancy is significantly lower in subfertile women with submu-
cous fibroids compared to other causes of subfertility according to
one systematic review and meta-analysis of 11 observational stud-
ies (Pritts 2001; Pritts 2009). Three observational studies found
a major benefit for removing a uterine septum by hysteroscopic
metroplasty in subfertile women with a uterine septum (Mollo
2009; Shokeir 2011; Toma evi 2010).
Why it is important to do this review
An updated National Institute for Health and Care Excellence
(NICE) guideline on fertility assessment and treatment states that
“ Women should not be offered hysteroscopy on its own as part
of the initial investigation unless clinically indicated because the
effectiveness of surgical treatment of uterine abnormalities on im-
proving pregnancy rates has not been established ” (NICE 2013).
However, there is a trend in reproductive medicine that is devel-
oping towards diagnosis and treatment of all major uterine cavity
abnormalities prior to fertility treatment. This evolution can be
explained by three reasons. First, diagnostic hysteroscopy is gener-
ally accepted in everyday clinical practice as the ’gold standard’ for
identifying uterine abnormalities because it allows direct visualisa-
tion of the uterine cavity (Golan 1996). Second, since 2004 several
randomised controlled trials (RCTs) have demonstrated the tech-
nical feasibility and the high patient satisfaction rate in women
undergoing both diagnostic and operative hysteroscopy for vari-
ous reasons including subfertility (Campo 2005;De Placido 2007;
Garbin 2006; Guida 2006; Kabli 2008; Marsh 2004; Sagiv 2006;
Shankar 2004; Sharma 2005). Third, in a subfertile population
screened systematically by diagnostic hysteroscopy, the incidence
of newly detected intrauterine pathology may be as high as 50%
(Campo 1999; De Placido 2007).
This review aimed to summarise and critically appraise the current
evidence on the effectiveness of operative hysteroscopic interven-
tions in subfertile women with major uterine cavity abnormal-
ities, both in women with unexplained subfertility and women
bound to undergo MAR. Since uterine cavity abnormalities may
negatively affect the uterine environment, and therefore the like-
lihood of conceiving (Rogers 1986), it has been recommended
that these abnormalities be diagnosed and treated by hysteroscopy
to improve the cost-effectiveness in subfertile women undergoing
MAR, where recurrent implantation failure is inevitably associated
with a higher economic burden to society.
The study of the association between subfertility and major uter-
ine cavity abnormalities might increase our current understanding
of the complex mechanisms of human embryo implantation. This
could lead to the development of cost-effective strategies in re-
productive medicine with benefits for both the individual woman
experiencing subfertility associated with major uterine cavity ab-
normalities as well as for society, in a broader perspective.
O B J E C T I V E S
To assess the effects of the hysteroscopic removal of endometrial
polyps, submucous fibroids, uterine septum or intrauterine adhe-
sions suspected on ultrasound, hysterosalpingography, diagnostic
hysteroscopy or any combination of thesemethods in women with
otherwise unexplained subfertility or prior to intrauterine insemi-
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nation (IUI), in vitro fertilisation (IVF) or intracytoplasmic sperm
injection (ICSI).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Inclusion criteria
• Trials that were either clearly randomised or claimed to be
randomised and did not have evidence of inadequate sequence
generation such as date of birth or hospital number were eligible
for inclusion.
• Cluster trials were eligible if the individually randomised
women were the unit of analysis.
• Cross-over trials were eligible for completeness but we
planned to use only pre-cross-over data for meta-analysis.
Exclusion criteria
• Quasi-randomised trials.
Types of participants
Inclusion criteria
• Women of reproductive age with otherwise unexplained
subfertility and endometrial polyps, submucous fibroids, septate
uterus or intrauterine adhesions detected by US, SIS, GIS, HSG,
diagnostic hysteroscopy or any combination of these methods.
Besides unexplained subfertility as the main clinical problem,
other gynaecological complaints, such as pain or bleeding, might
or might not be present.
• Women of reproductive age with subfertility, undergoing
IUI, IVF or ICSI with endometrial polyps, submucous fibroids,
septate uterus or intrauterine adhesions detected by US, SIS,
GIS, HSG, diagnostic hysteroscopy or any combination of these
methods.
Exclusion criteria
• Women of reproductive age with no major uterine cavity
abnormalities detected by US, SIS, GIS, HSG, diagnostic
hysteroscopy or any combination of these methods.
• Women of reproductive age with subfertility and
intrauterine cavity abnormalities other than endometrial polyps,
submucous fibroids, intrauterine adhesions and septate uterus,
for example, subserous or intramural fibroids without cavity
deformation on hysteroscopy, acute or chronic endometritis,
adenomyosis or other so-called ’subtle focal’ lesions.
• Women of reproductive age with endometrial polyps,
submucous fibroids, intrauterine adhesions or septate uterus
without subfertility.
• Women of reproductive age with recurrent pregnancy loss.
Types of interventions
We addressed two types of randomised interventions; within both
comparisons we stratified the suspected major uterine cavity ab-
normalities into endometrial polyps, submucous fibroids, uterine
septum and intrauterine adhesions. For the second comparison,
there was a stratification into IUI, IVF or ICSI.
• Operative hysteroscopy versus control in women with
otherwise unexplained subfertility and suspected major uterine
cavity abnormalities diagnosed by US, SIS, GIS, HSG,
diagnostic hysteroscopy or any combination of these methods.
• Operative hysteroscopy versus control in women
undergoing IUI, IVF or ICSI with suspected major uterine
cavity abnormalities diagnosed by US, SIS, GIS, HSG,
diagnostic hysteroscopy or any combination of these methods.
Types of outcome measures
Primary outcomes
• Effectiveness: live birth, defined as a delivery of a live foetus
after 20 completed weeks of gestational age that resulted in at
least one live baby born. The delivery of a singleton, twin or
multiple pregnancy was counted as one live birth.
• Adverse events: hysteroscopy complications, defined as any
complication due to hysteroscopy.
Secondary outcomes
• Pregnancy
◦ Ongoing pregnancy, defined as a pregnancy surpassing
the first trimester or 12 weeks of pregnancy.
◦ Clinical pregnancy with foetal heartbeat, defined as a
pregnancy diagnosed by US or clinical documentation of at least
one foetus with a heartbeat (Zegers-Hochschild 2017).
◦ Clinical pregnancy, defined as a pregnancy diagnosed
by US visualisation of one or more gestational sacs or definitive
clinical signs of pregnancy (Zegers-Hochschild 2017).
• Adverse events: miscarriage, defined as the spontaneous loss
of a clinical pregnancy before 20 completed weeks of gestation,
or if gestational age was unknown a foetus with a weight of 400 g
or less.
We planned to report the minimally important clinical difference
(MICD) for the primary outcome of live birth. An MICD of 5%
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for the live birth rate was predefined as being relevant for the
benefits. The imputation of this value was based on data from a
clinical decision analysis on screening hysteroscopy prior to IVF
(Kasius 2011b).
Search methods for identification of studies
An updated search was done in liaison with the Cochrane Gynae-
cology and Fertility (CGF) Group Information Specialist (Marian
Showell).
Two review authors (JB and SVW) independently performed a
comprehensive search of all published and unpublished reports
that described hysteroscopy in subfertile women with endome-
trial polyps, submucous fibroids, intrauterine adhesions or septate
uterus, or undergoing MAR. The search strategy was not limited
by language, year of publication or document format. We merged
all the retrieved citations from the CGF Specialised Register,
the Cochrane Central Register of Studies Online (CENTRAL),
MEDLINE, Embase, Web of Science, the BIOSIS PREVIEWS
and handsearch-related articles and removed duplicates using spe-
cialised software (EndNote Web 3.5; www.myendnoteweb.com/
EndNoteWeb.html; last done: 12 May 2018).
Electronic searches
For the 2018 update of this Cochrane Review, we searched the
following bibliographic databases, trial registers and websites:
The Cochrane Gynaecology and Fertility Group’s (CGF) Spe-
cialised Register, searched on 16 April 2018, PROCITE platform
(Appendix 1), CENTRAL Register of Studies Online (CRSO),
searched on 16 April 2018, web platform (Appendix 2), MED-
LINE OvidSP (searched from 1946 to 16 April 2018) (Appendix
3), and Embase OvidSP (searched from 1980 to 16 April 2018)
(Appendix 4).
The search strategy combined both index and free-text terms.
Our MEDLINE search included the Cochrane highly sensitive
search strategy for identifying randomised trials using the PubMed
format which appears in the Cochrane Handbook for Systematic
Reviews of Interventions (Section 6.4.11.1, box 6.4.a) (Higgins
2011).
Our Embase search included the SIGN trial filter developed by
the Scottish Intercollegiate Guidelines Network (www.sign.ac.uk/
methodology/filters.html#random).
Other electronic sources of trials were:
• Database of Abstracts of Reviews of Effectiveness ( DARE)
and the Health Technology Assessment Database ( HTA
Database) through the Centre for Reviews and Dissemination (
searched 12 May 2018) ( www.crd.york.ac.uk);
• National Guideline Clearinghouse ( www.guideline.gov) for
evidence-based guidelines (searched 12 May 2018);
• BIOSIS previews through ISI Web of Knowledge (
isiwebofknowledge.com) and CINAHL ( www.cinahl.com)
through EBSCOhost available at the Biomedical Library
Gasthuisberg of the Catholic University of Leuven (from 1961 to
1 May 2018) (Appendix 5);
• trial registers for ongoing and registered trials: Current
Controlled Trials ( www.controlled-trials.com),
ClinicalTrials.gov provided by the US National Institutes of
Health ( clinicaltrials.gov/ct2/home) and the WHO
International Clinical Trials Registry Platform search portal (
apps.who.int/trialsearch/) (searched 12 May 2018);
• citation indexes: Science Citation Index through Web of
Science ( scientific.thomson.com/products/sci/) - SCI-
EXPANDED (2014 to 12 May 2018) and Conference
Proceedings Citation Index - Science (CPCI-S) (2014 to 12 May
2018) and Scopus available at the Biomedical Library
Gasthuisberg of the Catholic University of Leuven) (from
inception to 12 May 2018);
• conference abstracts and proceedings on the ISI Web of
Knowledge ( isiwebofknowledge.com) applying ’SCI-
EXPANDED’ (2014 to 12 May 2018) and ’CPCI-S’ (2014 to
12 May 2018) (Appendix 6);
• LILACS database ( searched 12 May 2018) (
bases.bireme.br/cgi-bin/wxislind.exe/iah/online/?IsisScript=iah/
iah.xis&base=LILACS&lang=i&form=F) (searched 12 May
2018);
• European grey literature through Open Grey database (
searched to 12 May 2018) ( www.opengrey.eu/subjects/).
Searching other resources
Two review authors (JB and JK for the first published version, JB
and SVW for this update) independently handsearched the ref-
erence lists of reviews, guidelines, included and excluded studies,
and other related articles for additional eligible studies. One re-
view author (JB) contacted the first or corresponding authors of
included studies to ascertain if they were aware of any ongoing or
unpublished trials.
Two review authors (JB and JK for the first published version,
JB and SVW for this update) independently handsearched the
American Society for Reproductive Medicine (ASRM) conference
abstracts and proceedings (from 1 January 2014 to 12May 2018).
One review author (JB) contacted European experts and opinion
leaders in the field of hysteroscopic surgery to ascertain if these ex-
perts were aware of any relevant published or unpublished studies.
Data collection and analysis
Selection of studies
Two or three review authors were responsible for independently
selecting the studies (FB and TD for the first published version,
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JB, SVW and MB for this update). We scanned titles and ab-
stracts from the searches and obtained the full text of those ar-
ticles that appeared to be eligible for inclusion. We linked mul-
tiple reports of the same study together while citing all the ref-
erences and indicating the primary reference of the identified
study. On assessment, we categorised the trials as ’included stud-
ies’ (Characteristics of included studies table), ’excluded stud-
ies’ (Characteristics of excluded studies table), ’ongoing studies’
(Characteristics of ongoing studies table) or ’studies awaiting clas-
sification’ (Characteristics of studies awaiting classification table).
Any disagreements between both review authors who are content
experts were resolved through consensus or by a third review au-
thor (BWM for the first published version, SW for this update).
We contacted the first or corresponding authors of the primary
study reports for further clarification when required. If disagree-
ments between review authors were not resolved, we categorised
the studies as ’awaiting classification’ and reported the disagree-
ment in the final review. We avoided the exclusion of studies on
the basis of the reported outcome measures throughout the se-
lection phase by searching all potential eligible studies that could
have measured the primary or secondary outcomes even if these
were not reported. We appraised studies in an unblinded fashion,
as recommended by the CGF Group.
Data extraction and management
Two review authors, one methodologist (JB) and one topic area
specialist (SW), independently assessed the studies that appeared
to meet the inclusion criteria by using data extraction forms
based on the items listed in the protocol of this Cochrane Re-
view (Appendix 7). We pilot-tested the data extraction form and
process by reviewing 10 randomly chosen study reports. In the
pilot phase, two review authors consistently identified one re-
tracted record (Shokeir 2011) on the basis of finding duplicated
parts from another study included in the present Cochrane review
(Pérez-Medina 2005). For studies with multiple publications, we
used the main trial report as the primary data extraction source
and additional details supplemented from secondary papers if ap-
plicable. One review author (JB) contacted the first or correspond-
ing authors of the original studies to obtain clarification whenever
additional information on trial methodology or original trial data
was required. We sent reminder correspondence if a reply was not
obtained within two weeks. The two review authors resolved any
discrepancies in opinion by discussion; they searched for arbitra-
tion by a third review author if consensuswas not reached (BWM).
One review author (BWM) resolved disagreements which could
not be resolved by the review authors after contacting the first or
corresponding authors of the primary study reports. If this failed,
we reported the disagreement in the review.
Assessment of risk of bias in included studies
Two review authors (JB and SW) independently assessed the risk
of bias of the included studies using the Cochrane ’Risk of bias’
assessment tool that considers the following criteria, listed in the
CochraneHandbook for Systematic Reviews of Interventions (Chapter
8, tables 8.5.a and 8.5.b) (Higgins 2011): random sequence gen-
eration, allocation concealment, blinding of participants and per-
sonnel, blinding of outcome assessors, completeness of outcome
data, selective outcome reporting and other potential sources of
bias. We resolved any disagreements by consensus or by discussion
with a third review author (BWM). We presented the conclusions
in the ’Risk of bias’ table (Characteristics of included studies table),
with a full description of all judgements and incorporated them
into the interpretation of review findings by means of sensitivity
analyses.
We presented a narrative description of the quality of evidence,
which is necessary for the interpretation of the results of the review
and which is based on the review authors’ judgements on the risk
of bias of the included trials (Quality of the evidence).
Measures of treatment effect
For the dichotomous data for live birth, pregnancy, miscarriage
and hysteroscopy complications, we used the numbers of events
in the control and intervention groups of each study to calcu-
late Mantel-Haenszel odds ratios (OR). We presented 95% con-
fidence intervals (CI) for all outcomes. The OR has mathemat-
ically sound properties that are consistent with benefit or harm
and which work well in most RCTs on the effectiveness of repro-
ductive surgery given that sample sizes are usually small and trial
events are rare. Where data to calculate ORs were not available,
we planned to utilise the most detailed numerical data available
that might facilitate similar analyses of included studies (e.g. test
statistics, P values). We compared the magnitude and direction
of effect reported by studies with how they were presented in the
review, taking account of legitimate differences. We contacted the
corresponding or first authors of all included trials that reported
data in a form that was not suitable for meta-analysis, such as
time-to-pregnancy (TTP) data. We planned to report the data of
those reports that failed to present additional data that could be
analysed under ’other data’; we did not included TTP data in any
meta-analyses.
Unit of analysis issues
All primary and secondary outcomes were expressed as per woman
randomised. In addition,we reportednarrative data onmiscarriage
expressed as per pregnancy as a secondary analysis. We planned to
summarise reported data that did not allow a valid analysis, such
as ’per cycle’, in an additional table without any attempt at meta-
analysis. We countedmultiple live births andmultiple pregnancies
as one live birth or one pregnancy event. We planned to include
only first-phase data from cross-over trials, if available.
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Dealing with missing data
We aimed to analyse the data on an intention-to-treat (ITT) ba-
sis. We tried to obtain as much missing data as possible from the
original investigators. If this was not possible, we undertook im-
putation of individual values for the primary outcomes only. We
assumed that live births would not have occurred in participants
without a reported primary outcome. For all other outcomes, we
analysed only the available data. We subjected any imputation of
missing data for the primary outcomes to sensitivity analysis. If
there were substantial differences in the analysis as compared to
an available data analysis, we reported this in the review.
Assessment of heterogeneity
We planned to consider whether the clinical and methodologi-
cal characteristics of the included studies were sufficiently similar
for meta-analysis to provide a clinically meaningful summary, if
more randomised studies were included. We planned to carry out
a formal assessment of statistical heterogeneity using the I² statistic
combined with the Q-statistic. Cochrane’s Q test, a type of Chi²
statistic, is the classical measure to test significant heterogeneity.
Cochrane’s Q test is calculated as the weighted sum of squared
differences between individual study effects and the pooled effect
across studies. The Q-statistic follows Chi² distribution with k-1
degree of freedomwhere k is the number of studies. Q greater than
k-1 suggests statistical heterogeneity. A low P value of Cochrane’s
Q test means significant heterogeneous results among different
studies; usually, the P value at 0.10 is used as the cut-off. The Q-
statistic has low power as a comprehensive test of heterogeneity
especially when the number of studies is small. The Q-statistic
informs us about the presence or absence of heterogeneity; it does
not report on the extent of such heterogeneity. The I² statistic de-
scribes the percentage of variation across studies that is due to sig-
nificant heterogeneity rather than random chance. It measures the
extent of heterogeneity. An I² statistic greater than 50% was taken
to indicate substantial heterogeneity (Higgins 2003). We planned
to explore possible explanations for heterogeneity by performing
sensitivity analyses in Review Manager 5, if there was evidence of
substantial statistical heterogeneity (Review Manager 2014).
Assessment of reporting biases
In view of the difficulty in detecting and correcting for publication
bias, reporting bias and within-study reporting bias, we planned
to minimise their potential impact by ensuring a comprehensive
search for eligible studies and by being alert in identifying dupli-
cation of data. We aimed to detect within-trial selective reporting
bias, such as trials failing to report obvious outcomes, or reporting
them in insufficient detail to allow inclusion. We planned to seek
published protocols and to compare the outcomes between the
protocol and the final published study report. Where identified
studies failed to report the primary outcomes (e.g. live birth), but
did report interim outcomes (e.g. pregnancy), we would have un-
dertaken informal assessment as towhether the interim values were
similar to those reported in studies that also reported the primary
outcomes. If there were outcomes defined in the protocol or the
study report with insufficient data to allow inclusion, the review
indicated this lack of data and suggested that further clinical trials
need to be conducted to clarify these knowledge gaps. If there were
10 or more studies, we planned to create a funnel plot to explore
the possibility of small-study effects (a tendency for estimates of
the intervention effect to be more beneficial in smaller studies). A
gap on either side of the graph would have given a visual indication
that some trials had not been identified. Given the low number
of studies included in the final review, it was not possible to assess
reporting bias formally.
Data synthesis
One review author (JB) entered the data and carried out the statis-
tical analysis of the data usingReviewManager 5 (Review Manager
2014). We considered the outcomes live birth and pregnancy to
be positive and higher numbers as a benefit. We considered the
outcomes miscarriage and hysteroscopy complications in the pro-
tocol as negative effects and higher numbers harmful. These as-
pects were taken into consideration when assessing the summary
graphs. In the quantitative synthesis an increase in the odds of
a particular outcome, either beneficial or harmful, was displayed
graphically to the right of the centre-line and a decrease in the
odds of an outcome to the left of the centre-line.
We planned to combine data from primary studies in a meta-anal-
ysis with Review Manager 5 using the Peto method and a fixed-ef-
fect model (Higgins 2011) for the following comparisons, if more
randomised studies could have been included and if significant
clinical diversity and statistical heterogeneity could have been con-
fidently ruled out.
• Operative hysteroscopy versus control in women with
otherwise unexplained subfertility and suspected major uterine
cavity abnormalities diagnosed by US, SIS, GIS, HSG,
diagnostic hysteroscopy or any combination of these methods.
• Operative hysteroscopy versus control in women
undergoing MAR with suspected major uterine cavity
abnormalities diagnosed by US, SIS, GIS, HSG, diagnostic
hysteroscopy or any combination of these methods.
We planned to define analyses that were both comprehensive and
mutually exclusive so that all eligible study results were slotted into
one of the two predefined strata only. If there were no retrieved tri-
als for some comparisons, the review indicated their absence iden-
tifying knowledge gaps which need further research. Since meta-
analysis was not possible due to the limited number of studies
included in the review, we presented a narrative overview as pre-
specified in the protocol).
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Subgroup analysis and investigation of heterogeneity
We planned to carry out subgroup analyses to determine the sepa-
rate evidence within the following subgroups, if enough data were
available.
• Those studies that reported ’live birth’ and ’ongoing or
clinical pregnancy’ to assess any overestimation of effect and
reporting bias.
• For the two types of randomised comparison, stratified
according to the type of uterine abnormality, we planned to carry
out subgroup analyses according to the extent or severity of the
uterine abnormality. We used the length and diameter in
centimetres or calculated volumes of endometrial polyps and
submucous fibroids, the lengths and widths of uterine septa and
the European Society of Gynaecological Endoscopy (ESGE)
classification for intrauterine adhesions as references when
applicable (Wamsteker 1998).
• We planned to carry out subgroup analyses based on the
modifier participant age if enough studies were available.
The interpretation of the statistical analysis for subgroups is not
without problems. In the final review, we reported the interpreta-
tion of any subgroup analysis performed restrictively, if at all pos-
sible, and with utmost caution even if enough data were retrieved.
Sensitivity analysis
We aimed to perform sensitivity analyses for the primary outcomes
to determine whether the conclusions are robust to arbitrary de-
cisions made regarding the eligibility and analysis. These analyses
included consideration of whether conclusions would have dif-
fered if:
• eligibility was restricted to studies at low risk of bias in all
domains;
• alternative imputation strategies were adopted;
• a random-effects rather than a fixed-effect model was
adopted;
• the summary effect measure was risk ratio rather than OR.
Overall quality of the body of evidence: ’summary of
findings’ table
We prepared ’summary of findings’ tables using GRADE and
Cochrane methods (GRADEpro GDT; Higgins 2011). These ta-
bles evaluated the overall quality of the body of evidence for the
main review outcomes (primary outcome of effectiveness - live
birth - as well as secondary outcome of effectiveness - clinical preg-
nancy - and the adverse events - hysteroscopy complication and
miscarriage) for the two main review comparisons (randomised
comparison between operative hysteroscopy versus control for un-
explained subfertility associated with suspected major uterine cav-
ity abnormalities and randomised comparison between operative
hysteroscopy versus control for suspected major uterine cavity ab-
normalities prior toMAR).We assessed the quality of the evidence
using GRADE criteria: risk of bias, consistency of effect, impreci-
sion, indirectness and publication bias). Two review authors inde-
pendently made judgements about evidence quality (high, mod-
erate, low or very low), with disagreements resolved by discussion.
Judgements were justified, documented, and incorporated into re-
porting of results for each outcome.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies tables.
Results of the search
For the present update, there were 108 records from the CGFG
Specialised Register, 347 records from CRSO, 469 from MED-
LINE, 160 from Embase and 33 from Web of Science. An elec-
tronic search in DARE produced 50 records; there were 13 guide-
lines fromNational Guideline Clearinghouse, 25 records from the
ISRCTN register of controlled trials and 20 records from WHO
ICTRP. We identified 538 additional references in Scopus. We
identified 184 records in CINAHL and 59 records in LILACS
but none in Open Grey. We handsearched 400 abstracts in the
congress proceedings of the ASRM for the period 2014 to 2018;
we identified no additional abstracts after contacting the experts
of the European Society for Gynaecological Endoscopy (ESGE).
After combining 2006 records identified from electronic searches
with 400 additional records through handsearching, we screened
2406 records for duplicates by using a specialised software pro-
gram ( EndNote Web). After the removal of 561 duplicate refer-
ences, we screened the titles or abstracts, or both of 1845 records.
We removed 1683 records that were obviously irrelevant. We as-
sessed 162 full-text articles for eligibility. We did not include ad-
ditional RCTs in the updated version, so finally we included two
RCTs addressing the research questions of this Cochrane Review
(Characteristics of included studies table). We excluded 64 stud-
ies for various reasons (Characteristics of excluded studies table);
58 studies did not address the PICO research questions of this
Cochrane Review, four studies were not randomised, one was
a quasi-randomised trial and one potentially eligible RCT was
excluded (Shokeir 2010) because the study report had been re-
tracted at the request of the publisher. Two trials are still ongoing
(Characteristics of ongoing studies table).
See: PRISMA flow chart (Figure 1).
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Figure 1. Study flow diagram: summary of searches since 2014. CR: Cochrane Review; PICO: Population,
Intervention, Comparator, Outcome; RCT: randomised controlled trial; SR: systematic review.
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Included studies
Study design and setting
The review included two parallel-design RCTs. Both were single-
centre studies, one conducted in Italy (Casini 2006) and the other
in Spain (Pérez-Medina 2005).
Participants
One study included 94 women with submucous fibroids with or
without intramural fibroids and otherwise unexplained subfertil-
ity (Casini 2006). There were 52women in the intervention group
and 42 women in the control group. The mean participant age
was 31 years (range 29 to 34) in the subgroup of women with
submucous fibroids only and 32 years (range 30 to 35) in the sub-
group of women with mixed intramural-submucous fibroids. All
women underwent a complete fertility assessment. The presence
of uterine fibroids was by TVS. All women who were affected by
uterine fibroids excluding all other causes of infertility were asked
to participate in the study.Only women aged 35 years or less with a
problem of subfertility for at least one year and the presence of one
fibroid of diameter 40 mm or less were selected for randomisation.
Women older than 35 years or with other causes of infertility at the
performed examinations were excluded. Other exclusion criteria
were the presence of two or more fibroids of diameter greater than
40 mm; body weight greater than 20% of normal weight; and use
of medication containing oestrogens, progestins or androgens in
the eight weeks prior to the study.
The second study included 215 women with unexplained, male
or female factor infertility for at least 24 months bound to un-
dergo IUI with a sonographic diagnosis of endometrial polyps
(Pérez-Medina 2005). 11 women were lost to follow-up, six in the
intervention group and five in the control group. Data from 101
women in the intervention group and 103 women in the control
group were available for analysis.The mean participant age was 31
years (range 27 to 35). All women experienced primary subfer-
tility; they all underwent a complete fertility assessment. Unex-
plained infertility was diagnosed in women with normal ovulatory
cycles, semen analysis, HSG and postcoital testing. Female factor
infertility was diagnosed in women with ovulatory dysfunction,
cervical factor or endometriosis. Male factor infertility was diag-
nosed if two semen analyses obtained at least one month apart
were subnormal according to theWHO criteria. The sonographic
diagnosis of endometrial polyps was established by the demon-
stration of the vascular stalk of the endometrial polyp by colour
Doppler in a hyperechogenic formation with regular contours oc-
cupying the uterine cavity, surrounded by a small hypoechogenic
halo. Women older than 39 years of age or with anovulation or
uncorrected tubal disease or previous unsuccessful use of recombi-
nant follicle-stimulating hormone (FSH), as well as women with
a male partner with azoospermia, were excluded from randomisa-
tion.
For details of the inclusion and exclusion criteria, see
Characteristics of included studies table.
Interventions
One trial treated the intervention groupwith hysteroscopic surgery
to remove the fibroids; TVS was done three months after the pro-
cedure (Casini 2006).Women in the intervention group were sug-
gested to abstain from sexual intercourse for three months and
then to start having regular fertility-oriented intercourse. Women
in the control group were asked to immediately start having fer-
tility-oriented intercourse. Both groups were monitored for up to
12 months after study commencement.
The second trial performed all hysteroscopic interventions in an
outpatient clinic setting under local anaesthesia by one gynaecolo-
gist (Pérez-Medina 2005). In the intervention group, the endome-
trial polyps suspected on Doppler US were extracted by means of
rigid 1.5 mm scissors and forceps through the working channel
of a 5.5 mm continuous flow hysteroscope. All removed polyps
were submitted for histopathological examination. If resection was
not possible during the outpatient hysteroscopy, the woman was
scheduled for operative hysteroscopy under spinal anaesthesia in
the operating theatre of the hospital. All the hysteroscopic inter-
ventions were done in the follicular phase of the menstrual cycle.
The women of the intervention group were scheduled to receive
four cycles of IUI, using subcutaneous injections of FSH 50 IU
(international units) daily from the third day of the cycle. The first
IUI treatment cycle was started three cycles after the operative hys-
teroscopy. In the control group, the endometrial polyps suspected
on Doppler US were left in place during diagnostic hysteroscopy
using a 5.5 mm continuous flow hysteroscope; polyp biopsy was
performed to establish a histopathological diagnosis. All women
in the control group were scheduled to receive four cycles of IUI,
using subcutaneous injections of FSH 50 IU daily from the third
day of the cycle. The first IUI treatment cycle was scheduled three
cycles after the diagnostic hysteroscopy. Four IUI cycles were at-
tempted before finishing the trial.
Outcomes
Neither of the two included studies reported data on the primary
outcomes for this review, live birth and hysteroscopy complication
rates.
The first trial measured two secondary outcomes, clinical preg-
nancy and miscarriage rate (Casini 2006). A clinical pregnancy
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was defined by the visualisation of an embryo with cardiac activity
at six to seven weeks of pregnancy. Miscarriage was defined by the
loss of an intrauterine pregnancy between the seventh and 12th
weeks of gestation.
The second trial reported only one secondary outcome, the clin-
ical pregnancy rate (Pérez-Medina 2005). This was defined by a
pregnancy diagnosed by US visualisation of one or more gesta-
tional sacs.
The authors of one study gave a plausible explanation for the failure
to report on the live birth rate (Pérez-Medina 2005). They failed
to give an explanation for the lack of data on the other primary
outcome, the hysteroscopy complication rate. The study authors
of the other trial could not be contacted successfully for further
clarification on the absence of reporting the primary outcomes
(Casini 2006).
Excluded studies
We excluded 64 studies on hysteroscopic interventions for various
reasons.
• One randomised trial (Shokeir 2010) was excluded since
the main published report was retracted at the request of the
editor of the publishing journal as it duplicated parts of a paper
on a different topic that had already appeared in another journal
published years before (Pérez-Medina 2005).
• One trial was a quasi-randomised trial (Pabuccu 2008).
• Four trials were non-randomised studies (De Angelis 2010;
Gao 2013; Mohammed 2014; Trnini -Pjevi 2011).
• Fifty-eight randomised trials did not address the
prespecified PICO (Participants, Interventions, Comparisons
and Outcomes) research questions of this Cochrane Review.
◦ Fourteen trials studied the effectiveness of
hysteroscopy in subfertile women bound to undergo IVF or ICSI
treatment with unsuspected or no uterine cavity abnormalities
(Abiri 2014; Aghahosseini 2012; Aleyassin 2017; Basma 2013;
Demirol 2004; Di Florio 2013; El-Nashar 2011; Elsetohy 2015;
El-Toukhy 2009; Fatemi 2007; Rama Raju 2006; Shawki 2012;
Smit 2016; Sohrabvand 2012).
◦ One trial assessed the effectiveness of hysteroscopy
prior to IUI in women with no previously detected uterine
anomalies (Moramezi 2012).
◦ Three trials assessed the effectiveness of endometrial
injury (El-Khayat 2015; Hare 2013; Weiss 2005).
◦ Twelve trials had a study population that included
women who were not of reproductive age experiencing
gynaecological problems other than subfertility (Clark 2015;
Hamerlynck 2015; Javidan 2017; Kamel 2014; Lara-Dominguez
2016; Lieng 2010a; Muzii 2007; Muzii 2017; Nappi 2013;
Rubino 2015; Smith 2014; van Dongen 2008).
◦ Two trials had a study population that included only
women with repeated miscarriage (Vercellini 1993) or recurrent
implantation failure (Cao 2018).
◦ Eighteen trials studied the effectiveness of adjunctive
therapies (hyaluronic acid gel, amnion graft, balloon catheter,
cyclical hormone replacement therapy alone or intrauterine
device alone or both cotreatments combined, autologous platelet
rich plasma) for the prevention of intrauterine adhesions
following hysteroscopic adhesiolysis (Abu Rafea 2013; Acunzo
2003; Aghajanova 2018; Amer 2010; De Iaco 2003; Di Spiezio
Sardo 2011; Fuchs 2014; Gan 2017; Guida 2004; Guo 2017;
Hanstede 2016; Lin 2014; Liu 2016; Paz 2014; Revel 2011; Roy
2014; Tonguc 2010; Xiao 2015).
◦ Six trials compared different surgical techniques for
treating uterine septum in a mixed study population of women
with subfertility or recurrent pregnancy loss (Colacurci 2007;
Darwish 2009; Parsanezhad 2006; Roy 2015; Roy 2017; Youssef
2013).
◦ One trials assessed the interobserver agreement of
gynaecologists performing hysteroscopy for a septate uterus who
received instructions on the assessment of the septum prior to
the procedure versus gynaecologists who did not (Smit 2015).
◦ One trial was an RCT investigating the effects of
mindfulness-based stress reduction on anxiety, depression and
quality of life in women with intrauterine adhesions (Chen
2017).
See: Characteristics of excluded studies table.
Studies awaiting classification
We found no studies awaiting classification.
Ongoing studies
We retrieved two ongoing studies (SEPTUM trial; TRUST trial).
The TRUST trial is a multicentre RCT. The starting date was 1
October 2008. The sample size of this study is 68 women; on 4
May 2018 the 63rd participant was included.
The SEPTUM trial was designed as a pilot multicentre RCT to
assess the feasibility for a larger adequately powered trial. The
trial is closed to further recruitment due to feasibility issues with
recruitment. Six participants were included and will be followed
up for 24months post intervention (personal correspondence with
Dr Matthew Prior).
See: Characteristics of ongoing studies table.
Risk of bias in included studies
See the ’Risk of bias’ summary for the review authors’ judgements
about each risk of bias item in the included study (Figure 2).
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
See the ’Risk of bias’ graph for the review authors’ judgements
about each risk of bias item presented as percentages across the
two included studies (Figure 3).
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Figure 3. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
We judged both studies at low risk of selection bias related to
random sequence generation, as both used computerised random
numbers tables (Casini 2006; Pérez-Medina 2005).
We judged one study at low risk for selection bias related to allo-
cation concealment, as they used sequentially numbered, opaque,
sealed envelopes to conceal the random allocation of women to
one of the comparison groups (Pérez-Medina 2005). We judged
the second trial at unclear risk for selection bias related to allo-
cation concealment since the method used was not reported and
no further clarification by the authors could be obtained (Casini
2006).
Blinding
We judged both studies at low risk of performance and detection
bias since both surgical studies had unequivocal outcomes that
are most likely not affected by unclear blinding of participants,
personnel and outcome assessors (Casini 2006; Pérez-Medina
2005). Themethodswere not reported and no further clarification
could be obtained.
Incomplete outcome data
We judged both studies at low risk of attrition bias. One study
reported outcome data of all randomised women (Casini 2006).
The second study analysed the majority of women randomised
(95%) (Pérez-Medina 2005). The missing outcome data in the
remaining 5% were balanced in numbers with similar reasons for
missing data between the two comparison groups.
Selective reporting
We judged both studies at high risk of reporting bias (Casini 2006;
Pérez-Medina 2005). Both studies failed to include data for the
primary outcome live birth, which could reasonably have been
reported in studies conducted over a seven-year (Casini 2006)
and a four-year (Pérez-Medina 2005) period. Although a plausible
explanation was given by the contact author of one study (Pérez-
Medina 2005), we judged that it could have beenpossible to obtain
data on the live birth rates if the study authors had contacted the
referring gynaecologists (see Characteristics of included studies
table). Moreover, one trial reported no data on adverse outcomes
such as miscarriage or hysteroscopy complications (Pérez-Medina
2005), whereas the second study reported miscarriage rates only
for the adverse events (Casini 2006).
Other potential sources of bias
We judged one study to be at unclear risk of other potential sources
of bias (Casini 2006). The study did not report the mean ages
and duration of infertility in the intervention and control group
of women with submucous fibroids; we were unable to obtain
these data from the study authors given that we were unsuccessful
in contacting them. It is unclear whether this might have caused
imbalance in the baseline characteristics between the comparison
groups in this randomised trial (Casini 2006).Moreover, it was un-
clear whether hysteroscopy had been performed in all participants
to confirm the position of the ultrasonically detected fibroids.
We judged the second study at low risk of other potential sources
of bias since there was no evidence of baseline imbalance in the
participant characteristics between the two comparison groups (
Pérez-Medina 2005).
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Publication bias could not be formally assessed due to the very
limited number of studies included in this Cochrane Review.
Effects of interventions
See: Summary of findings for the main comparison Operative
hysteroscopy versus control in women with otherwise unexplained
subfertility and suspected major uterine cavity abnormalities;
Summary of findings 2 Operative hysteroscopy versus control
in women undergoing medically assisted reproduction with
suspected major uterine cavity abnormalities
1. Operative hysteroscopy versus control in women
with otherwise unexplained subfertility and suspected
major uterine cavity abnormalities
See: Summary of findings for the main comparison.
Endometrial polyps
The search identified no studies on endometrial polyps.
Submucous fibroids
One study compared hysteroscopic myomectomy versus no
surgery in women with unexplained subfertility and submucous
fibroids only or combined with intramural fibroids (Casini 2006).
Primary outcomes
Live birth
There were no data for live births.
Adverse events: hysteroscopy complications
There were no data for hysteroscopy complications.
Secondary outcomes
Clinical pregnancy
In womenwith otherwise unexplained subfertility and submucous
fibroids, we were uncertain whether hysteroscopic myomectomy
improved the clinical pregnancy rate compared to expectant man-
agement (OR 2.44, 95% CI 0.97 to 6.17; P = 0.06, 94 women;
Analysis 1.1; Figure 4).
Figure 4. Forest plot of comparison: 1 Hysteroscopic myomectomy vs no surgery in women with
unexplained subfertility and submucous fibroids. Outcome: 1.1 Clinical pregnancy per woman randomised.
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Adverse events: miscarriage
There was insufficient evidence to determine whether there was
a difference between the removal of one submucous fibroid of
diameter 40 mm or less in women with otherwise unexplained
subfertility for at least one year versus expectant management for
the outcome of miscarriage per woman randomised (OR 1.54,
95% CI 0.47 to 5.00; P = 0.47, 94 women; Analysis 1.2; Figure
5). As a secondary analysis, we reported the miscarriage rate per
clinical pregnancy. There was insufficient evidence to determine
whether there was a difference between the groups (OR 0.58, 95%
CI 0.12 to 2.85; P = 0.50, 30 clinical pregnancies in 94 women).
Figure 5. Forest plot of comparison: 1 Hysteroscopic myomectomy vs no surgery in women with
unexplained subfertility and submucous fibroids. Outcome: 1.2 Miscarriage per clinical pregnancy.
Subgroup analyses
We performed no subgroup analyses across studies to assess any
overestimation of treatment effect or reporting bias, due to the
limited number of studies.
One prespecified subgroup analysis within the trial was done for
the two secondary outcomes of clinical pregnancy and miscarriage
according to whether submucous fibroids only or mixed submu-
cous-intramural fibroids were considered. There was insufficient
evidence to determine whether there was a difference for the sec-
ondary outcome clinical pregnancy between the ’submucous only’
subgroup (OR 2.04, 95% CI 0.62 to 6.66; P = 0.24, 1 RCT, 52
women) and the ’mixed submucous-intramural’ subgroup (OR
3.24, 95% CI 0.72 to 14.57; P = 0.13, 1 RCT, 42 women); the
tests for subgroup differences demonstrated no statistical hetero-
geneity beyond chance (Chi² = 0.22, degrees of freedom (df ) =
1; P = 0.64, I² = 0%). There was insufficient evidence to deter-
mine whether there was a difference for the secondary outcome
miscarriage between the ’submucous only’ subgroup (OR 0.63,
95% CI 0.09 to 4.40; P = 0.64, 1 RCT, 19 clinical pregnancies in
52 women) and the ’mixed submucous-intramural’ subgroup (OR
0.50, 95% CI 0.03 to 7.99; P = 0.62, 1 RCT, 11 clinical preg-
nancies in 42 women); the tests for subgroup differences demon-
strated no statistical heterogeneity beyond chance (Chi² = 0.02,
df = 1, P = 0.90, I² = 0%).
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Uterine septum
There were no data for uterine septum.
Intrauterine adhesions
There were no data for intrauterine adhesions.
2. Operative hysteroscopy versus control in women
undergoing medically assisted reproduction with
suspected major uterine cavity abnormalities
See: Summary of findings 2.
Endometrial polyps prior to intrauterine insemination
One study compared hysteroscopic removal of polyps versus
diagnostic hysteroscopy and polyp biopsy in women with en-
dometrial polyps undergoing gonadotropin treatment and IUI
(Pérez-Medina 2005).
Primary outcomes
Live birth
There were no data for live births.
Adverse events: hysteroscopy complications
There were no data for hysteroscopy complications.
Secondary outcomes
Clinical pregnancy
The hysteroscopic removal of polyps prior to IUI may have im-
proved the clinical pregnancy rate compared to diagnostic hys-
teroscopy only: if 28% of women achieved a clinical pregnancy
without polyp removal, the evidence suggested that 63%ofwomen
(95% CI 45% to 89%) would have achieved a clinical pregnancy
after the hysteroscopic removal of the endometrial polyps (OR
4.41, 95% CI 2.45 to 7.96; P < 0.00001, 204 women; Analysis
2.1; Figure 6). The number needed to treat for an additional ben-
eficial outcome was 3 (95% CI 2 to 4).
Figure 6. Forest plot of comparison: 2 Hysteroscopic removal of polyps vs diagnostic hysteroscopy and
biopsy only prior to intrauterine insemination. Outcome: 2.1 Clinical pregnancy per woman randomised.
Adverse events: miscarriage
There were no data for miscarriage.
Subgroup analyses
We performed no subgroup analyses across studies to assess any
overestimation of treatment effect or reporting bias given the lim-
ited number of studies.
We performed the following two subgroup analyses within the
included study.
Afirst prespecified subgroup analysis studied the effect of polyp size
on the secondary outcome of clinical pregnancy. On histopatho-
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logical examination, the mean size of the polyps removed was 16
mm (range 3 mm to 24 mm). The primary study examined the ef-
fect of polyp size on the clinical pregnancy rate in the intervention
group. They analysed the data based on the size of the removed
polyps, subdivided into four groups based in their quartiles (less
than 5mm, 5mm to 10mm, 11mm to 20mmand greater than 20
mm); there was insufficient evidence to determine whether there
was a difference between these four subgroups given the limited
number of data (P = 0.32) (Table 1). There was no evidence of an
effect of polyp size on the outcome of clinical pregnancy, but these
results should be interpreted carefully given the limited numbers
in only one included study. There were no data on the estimated
size of the polyps in the control group.
The second subgroup analysis studied the effect of the timingof the
IUI treatment after hysteroscopy on the secondary outcome clin-
ical pregnancy. About 29% of women in the polypectomy group,
compared to 3% in the diagnostic hysteroscopy group, became
pregnant in the three-month period after the hysteroscopy before
the treatment with gonadotropin and IUI was started; this was cal-
culated from the Kaplan-Meier survival analysis in the published
report of the primary study (Pérez-Medina 2005). Hysteroscopic
polypectomy may have improved the clinical pregnancy rate com-
pared to diagnostic hysteroscopy and polyp biopsy inwomenwait-
ing to be treated with gonadotropin and IUI (OR 13, 95% CI 3.9
to 46; P < 0.0001, 1 study, 204 women; available-data analysis).
The number needed to treat to for an additional beneficial out-
come after hysteroscopic polypectomy while waiting for further
treatment with gonadotropin and IUI was 4 (95% CI 3 to 6). In
women who started gonadotropin and IUI treatment the preg-
nancy rates per woman were 49% in the intervention group and
26% in the control group, calculated from data in the published
report of the primary study (Pérez-Medina 2005). Hysteroscopic
polypectomy may have improved the clinical pregnancy rate in
women who started from three months after the surgical proce-
dure with gonadotropin and IUI treatment (OR 2.7, 95% CI 1.4
to 5.1; P = 0.003, 1 RCT, 172 women; available-data analysis).
The number needed to treat for an additional beneficial outcome
when treated with gonadotropin and IUI after a prior hystero-
scopic polypectomy was 4 (95% CI 3 to 12). This was a post hoc
subgroup analysis. Quoting from the primary study published re-
port “A second important conclusion in our study is that preg-
nancies after polypectomy are frequently obtained spontaneously
while waiting for the treatment, suggesting a strong cause-effect
of the polyp in the implantation process. This led us to defer the
first IUI to three menstrual cycles after the polypectomy is per-
formed. Longer series are needed to verify these results”. Data from
this subgroup analysis should be treated with caution as subgroup
analysis by itself is observational in nature, and statistical interpre-
tation of its results is not without problems.
Sensitivity analyses
A sensitivity analysis comparing an ITT analysis assuming that
clinical pregnancies would not have occurred in participants with
missing data, rather than an available-data analysis, did not affect
the statistical significance of the main analysis for the secondary
outcome clinical pregnancy (OR 4.0, 95% CI 2.3 to 7.2; P <
0.00001; 1 RCT, 215 women randomised). No other imputation
strategies for dealing with the missing data were assumed given
the limited number of studies.
Endometrial polyps prior to in vitro fertilisation or
intracytoplasmic sperm injection
We found no studies on endometrial polyps prior to IVF or ICSI.
Submucous fibroids prior to intrauterine insemination, in
vitro fertilisation or intracytoplasmic sperm injection
We found no studies on submucous fibroids prior to IUI, IVF or
ICSI.
Uterine septum prior to intrauterine insemination, in vitro
fertilisation or intracytoplasmic sperm injection
We found no studies on uterine septum prior to IUI, IVF or ICSI.
Intrauterine adhesions prior to intrauterine insemination, in
vitro fertilisation or intracytoplasmic sperm injection
We found no studies on intrauterine adhesions prior to IUI, IVF
or ICSI.
Other analyses
We planned to do sensitivity analyses for Analysis 1.1; Analysis
1.2; and Analysis 2.1 to consider whether conclusions would have
differed if eligibility had been restricted to studies at low risk of
bias in all domains. We retrieved only one study for each random
comparison. Moreover for both studies there was at least one item
at high risk of bias (Figure 2). Hence no sensitivity analyses were
performed in the present updated Cochrane Review.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Operative hysteroscopy versus control in women undergoing medically assisted reproduction with suspected major uterine cavity abnormalities
Patient or population: subfert ile women with endometrial polyps diagnosed by ultrasonography prior to treatment with gonadotropin and intrauterine inseminat ion
Settings: infert ility unit of a university tert iary hospital in Madrid, Spain
Intervention: hysteroscopic polypectomy using a 5.5 mm continuous f low of f ice hysteroscope with a 1.5 mm scissors and forceps
Comparison: diagnost ic hysteroscopy using a 5.5 mm continuous f low of f ice hysteroscope and polyp biopsy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Polypectomy
Live birth No data reported.
Adverse events: hys-
teroscopy complica-
tions
No data reported.
Clinical pregnancya
Ultrasound
4 intrauterine insemina-
t ion cycles
282 per 1000 634 per 1000
(451 to 894)
OR 4.41
(2.45 to 7.96)
204
(1 study)
⊕⊕©©
Lowb,c
-
Adverse events: mis-
carriage
No data were reported for this secondary outcome.
* The basis for the assumed risk is the control group risk of the single included study (Pérez-Medina 2005). The corresponding risk (and its 95% conf idence interval) is based
on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io.
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GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: we are very uncertain about the est imate.
aClinical pregnancy was def ined by the presence of at least one gestat ional sac on ultrasound.
bDowngraded by one level for serious risk of bias (high risk for select ive outcome report ing).
cDowngraded by one level for serious imprecision (wide conf idence interval of the ef fect size est imate).
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D I S C U S S I O N
Summary of main results
This systematic review aimed to investigate whether the hystero-
scopic treatment of suspected major uterine cavity abnormalities
made a difference to the main outcomes of live birth or pregnancy
and the adverse events (hysteroscopy complications and miscar-
riage) in subfertile women with otherwise unexplained subfertil-
ity or before IUI, IVF or ICSI. We searched for studies on two
randomised comparisons to study the effectiveness of operative
hysteroscopy in the treatment of subfertility associated with major
uterine cavity abnormalities.
The first randomised comparison was operative hysteroscopy ver-
sus control in women with otherwise unexplained subfertility and
suspected major uterine cavity abnormalities - stratified into en-
dometrial polyps, submucous fibroids, intrauterine adhesions or
septate uterus - diagnosed by US, SIS/GIS, HSG, diagnostic hys-
teroscopy or any combination of these methods (Summary of
findings for the main comparison). We retrieved and critically ap-
praised only one trial in this category comparing the hysteroscopic
removal of one submucous fibroid with a diameter of 40 mm or
less in women aged 35 years or less with otherwise unexplained
subfertility versus expectant management (no surgery followed by
fertility-oriented intercourse) (Casini 2006). There was insuffi-
cient evidence to determine whether there was a difference be-
tween groups. This may have been due to a type II error: we calcu-
lated that a sample size of 91 participants was needed to detect a
difference of 19% for the outcome of clinical pregnancy between
groups with a statistical power of 80% at a confidence level of 95%
(α = 0.05 and β = 0.20). In other words, a study population of
at least 182 participants is needed to detect any statistically sig-
nificant difference if present; compared to only 94 women in the
study (Casini 2006). There was insufficient evidence to determine
whether there was a difference between groups for the miscarriage
rate. We found no data on live birth or hysteroscopy complication
rates. We found no studies in women with endometrial polyps,
intrauterine adhesions or septate uterus for this randomised com-
parison.
The second randomised comparison was operative hysteroscopy
versus control in women undergoing MAR - stratified into IUI,
IVF or ICSI - with suspected major uterine cavity abnormali-
ties - stratified into endometrial polyps, submucous fibroids, in-
trauterine adhesions or septate uterus - diagnosed by US, SIS,
GIS, HSG, diagnostic hysteroscopy or any combination of these
methods (Summary of findings 2). We retrieved and critically ap-
praised one trial in this category randomly comparing hystero-
scopic polypectomy versus diagnostic hysteroscopy comparison in
subfertile women with suspected endometrial polyps bound to
undergo IUI (Pérez-Medina 2005). The hysteroscopic removal of
polyps with a mean size of 16 mm (range 3 mm to 24 mm) may
have improved clinical pregnancy rates compared to simple di-
agnostic hysteroscopy. A sensitivity analysis on the choice to use
an ITT analysis by making the imputation that clinical pregnan-
cies would not have occurred in participants with missing data
rather than an available-data analysis did not demonstrate an im-
pact on the overall results. We found no data for live birth, hys-
teroscopy complication or miscarriage rates. The increase in clini-
cal pregnancy rates following hysteroscopic polypectomy was due
to a higher proportion of spontaneous conceptions before starting
IUI and a higher chance of conceiving after starting gonadotropin
treatment and IUI. The results of this post hoc subgroup anal-
ysis should be interpreted with caution. We found no studies in
women with submucous fibroids, intrauterine adhesions or sep-
tate uterus prior to IUI or in women with all types of suspected
uterine cavity abnormalities prior to IVF or ICSI.
Due to the lack of studies, there was no formal assessment of
publication bias.
Overall completeness and applicability of
evidence
Evidence on the effectiveness of treating suspected major uter-
ine cavity abnormalities by operative hysteroscopy compared to a
control intervention in women with otherwise unexplained sub-
fertility was insufficient. We found no trials on the hysteroscopic
treatment of endometrial polyps, intrauterine adhesions or uterine
septum compared to a control intervention in women with oth-
erwise unexplained subfertility. The only included study in this
category failed to report on the primary outcomes for this review.
Evidence on the effectiveness of operative hysteroscopy compared
to control in subfertile women with associated major uterine cav-
ity abnormalities prior to MAR was incomplete since data had
been found only for subfertile women with suspected endometrial
polyps prior to IUI. The search found no data on the effectiveness
of operative hysteroscopy versus control in subfertile women with
other suspected major cavity abnormalities such as submucous fi-
broids, intrauterine adhesions or uterine septum prior to IUI or
other techniques such as IVF or ICSI for all outcomes. Moreover,
for the randomised comparison of hysteroscopic polypectomy ver-
sus diagnostic hysteroscopy prior to IUI, there were no data avail-
able for the primary outcomes. The evidence retrieved was by con-
sequence insufficient to address all the objectives of the present
Cochrane Review.
The uncertainty of whether there were differences between the
comparison groups in the trial of hysteroscopic myomectomy in
women with submucous fibroids and otherwise unexplained sub-
fertility did not exclude a clinically relevant benefit with the hys-
teroscopic removal of fibroids. It is generally accepted that sub-
mucous fibroids are very likely to interfere with normal fertility
(Pritts 2001; Pritts 2009). In everyday practice, most skilled hys-
teroscopic surgeons will counsel women with submucous fibroids
associated with otherwise unexplained subfertility or bound to be
treated with IUI, IVF or ICSI to have the submucous fibroids re-
moved before further expectant management or MAR; besides of-
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fering participation in a pragmatic RCT on this topic there seems
no other sound clinical alternative.
Although the results of the trial on hysteroscopic polypectomy are
relevant for everyday practice (Pérez-Medina 2005), one-third of
the randomised women treated by IUI had an ovulatory disorder
other than anovulation. In everyday clinical practice, ovulatory
disorder is by itself not an indication for IUI as opposed to male
factor (Bensdorp 2007) and unexplained subfertility (Veltman-
Verhulst 2012). We have considered doing a sensitivity analysis to
determine if the inclusion and exclusion of women with ovulatory
disorders could have influenced the magnitude of the treatment
effect but failed to obtain the data from the study authors.
Quality of the evidence
See Table 2; Table 3; Summary of findings for the main
comparison; Summary of findings 2.
The present review included only two trials; neither reported the
primary outcomes live birth or hysteroscopy complications.
We graded the evidence using the GRADE tool (GRADEpro
GDT) of the trial on hysteroscopic myomectomy as very low (
Casini 2006). It was a small studywith few events.We downgraded
by two levels for very serious risk of bias: there was uncertainty
about allocation concealment, it was unclear whether there was
imbalance in the baseline characteristics of the study groups and
there was a high risk of selective outcome reporting. Moreover, we
downgraded by one level for serious imprecision given the wide
CIs of the point estimate of the treatment effect.
We graded the evidence of the trial on hysteroscopic polypectomy
as low (Pérez-Medina 2005): we downgraded by one level for
serious risk of bias related to a high risk of selective outcome
reporting (see Assessment of risk of bias in included studies). We
downgraded by one level for serious imprecision given the wide
CIs of the point estimate of the treatment effect.
Potential biases in the review process
There is an earlier published version of this review (Bosteels 2010).
Given our prior knowledge of potentially eligible studies for this
clinical research topic, theremight have been somepotential for de-
tectionbias.We carried out a comprehensive literature search using
a search strategy that was more extensive than the one used in the
earlier published systematic review. This enabled us to identify a
far greater number of randomised studies on hysteroscopic surgery
in subfertile women, many of which did not address the particular
research questions prespecified in the protocol (see Characteristics
of excluded studies table).
Agreements and disagreements with other
studies or reviews
According to one systematic review and critical appraisal, robust
and high-quality RCTs are needed before hysteroscopy can be
regarded as a first-line procedure in all infertile women, especially
during the basal clinical assessment of the couple, when assisted
reproductive treatment is not indicated yet (Di Spiezio Sardo
2016).
The findings and conclusions on the evidence for the removal of
fibroids by hysteroscopy are in accordance with the findings of one
Cochrane Review (Metwally 2012). The authors concluded that
there was currently no definitive evidence from RCTs regarding
the effect of hysteroscopic myomectomy on fertility outcomes. In
contrast, according to the findings and conclusions of two sys-
tematic reviews of observational studies on fibroids and subfertil-
ity, fertility outcomes are decreased in women with submucosal
fibroids, and removal is likely to benefit the reproductive outcome
(Pritts 2001; Pritts 2009).
One Cochrane Review concluded that additional well-designed
RCTs on the effectiveness of hysteroscopic polypectomy for im-
proving reproductive outcome in subfertile women are needed,
which is in accordancewith our findings (Jayaprakasan 2014).One
systematic review of mainly very-low quality observational studies
concluded that polypectomy appeared to have a favourable out-
come in infertile women (Lieng 2010b). Nevertheless, the body
of evidence supporting the removal of endometrial polyps is lim-
ited, and future research evaluating the outcome of this common
procedure is required.
One Cochrane Review concluded that there was no evidence to
support hysteroscopic septum resection in women of reproductive
age with a septate uterus to improve reproductive outcomes, al-
though this procedure is often performed worldwide for this indi-
cation (Rikken 2017). RCTs are urgently needed (Rikken 2016):
two studies are ongoing (SEPTUM trial; TRUST trial).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In womenwith otherwise unexplained subfertility and submucous
fibroids, we are uncertain whether clinical pregnancy rates im-
proved after hysteroscopic myomectomy compared to expectant
management because there was only one small single-centre study
of very low quality.
Hysteroscopic polypectomy may improve the chance of conceiv-
ing compared to diagnostic hysteroscopy only in subfertile women
with a sonographic diagnosis of endometrial polyps prior to in-
trauterine insemination (IUI) for unexplained, male or female fac-
tor infertility for at least 24 months. The quality of the single-
centre study retrieved was low.
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Implications for research
The evidence retrieved from only two randomised studies was
insufficient to address all the objectives of the present Cochrane
Review.
More well-designed randomised controlled trials are needed to
assess whether the hysteroscopic removal of endometrial polyps,
submucous fibroids, septa or intrauterine adhesions is likely to
benefit women with otherwise unexplained subfertility associated
with these suspected uterine pathologies compared to a control in-
tervention. Equally, more clinical research is needed on the effec-
tiveness of treating endometrial polyps, submucous fibroids, septa
or intrauterine adhesions in subfertile women bound to undergo
IUI, in vitro fertilisation (IVF) or intracytoplasmic sperm injec-
tion (ICSI).
There are knowledge gaps concerning the effects of the number,
size or extent and the localisation of the major uterine cavity ab-
normalities on the main outcomes in women with otherwise un-
explained subfertility or prior to medically assisted reproduction.
Well-designed randomised studies are needed to assess the rela-
tionship between the timing of the hysteroscopic intervention and
subsequent IUI, IVF or ICSI treatment.
Future randomised studies should report on primary outcomes
such as live birth and adverse events such as miscarriage and hys-
teroscopic complications.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Casini 2006
Methods Parallel-group, randomised, controlled, single-centre trial
Power calculation not reported
Approved by the hospital’s ethics committee
No source of funding or conflict of interest reported
Participants Country: Italy
Setting: AGUNCO Obstetrics and Gynecology Centre, Rome
Population: women referred to the centre from January 1998 to April 2005 for fertil-
ity problems were examined for inclusion. All women underwent routine examinations
including the study of ovarian function (FSH, luteinising hormone, oestradiol and pro-
gesterone concentrations); prolactin, free triiodothyronine, free thyroxine and thyroid-
stimulating hormone concentrations; postcoital test; TVUS; HSG and analysis of the
partner’s semen. The TVUS was performed to diagnose the presence of uterine fibroids.
After these examinations, all women found to be affected by uterine fibroids excluding
all other causes of infertility were asked to participate in the study
Type of subfertility: infertility for ≥ 1 year (range: 1 to 5 years); no further clarification
on primary versus secondary subfertility
Mean age: women with submucous fibroids alone: 31.4 ± 2.5 years; women with mixed
submucous-intramural fibroids: 32.2 ± 2.5 years
Number recruited: 193 women
Number participants: 181 women
Number participants with submucous fibroids only: 52 women
Number participants with mixed submucous-intramural fibroids: 42 women
Inclusion criteria: aged ≤ 35 years; infertility for ≥ 1 year; presence of 1 knot or fibroid
of diameter≤ 40mm (or both) and absence of other causes of infertility at the performed
examinations
Exclusion criteria: presence of ≥ 2 knots or fibroids of diameter > 40 mm (or both)
; body weight > 20% of normal weight; and use of medication containing oestrogens,
progestins or androgens within 8 weeks prior to study
Duration of study: 86 months; conducted January 1998 to April 2005
Interventions • Intervention group: hysteroscopic surgery to remove fibroids (52 women)
• Control group: not treated (42 women)
Participants were examined by TVUS 3 months after surgery.
Participants who underwent surgery were suggested to abstain from having sexual in-
tercourse for 3 months and then to start having regular fertility-oriented intercourse.
Participants who did not undergo surgery were asked to immediately start having regular
fertility-oriented intercourse (intercourse during the 6-day fertile interval ending on the
day of ovulation)
Participants were monitored for up to 12 months after study commencement
Outcomes Clinical pregnancy defined by the visualisation of an embryo with cardiac activity at 6-
7 weeks of pregnancy
Miscarriage classified as clinical loss of an intrauterine pregnancy between the 7th and
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Casini 2006 (Continued)
12th weeks of gestation
Notes Authors stated that the differences in pregnancy rates between the comparison groups
were statistically significant for the women with submucous fibroids (P < 0.05), which
is in contrast with the calculation of the results in Review Manager 5
The definition of knot was unclear: it could not be clarified since we were unable to
contact the study authors
Unclear whether a hysteroscopy was done in all women to confirm the exact position of
the ultrasonically detected fibroids
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subsequently, women of each
group were randomized into two sub-
groups, according to a randomisation table.
”
Comment: low risk of selection bias related
to random sequence generation
Allocation concealment (selection bias) Unclear risk Method not stated: no further clarification
obtained from the study authors
Comment: unclear risk of selection bias re-
lated to allocation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Method not stated: no further clarification
obtained from the study authors
Comment: not applicable as this is a surgi-
cal study with unequivocal outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Method not stated: no further clarification
obtained from the study authors
Comment: not applicable as this is a surgi-
cal study with unequivocal outcomes
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “One hundred and ninety-three pa-
tients were diagnosed as affected by uterine
fibroid excluding all other causes of infertil-
ity and met the requirements of the inclu-
sion and exclusion criteria. Of these, 181
decided to participate in the study. Among
the 181 patients, 52 had submucosal fi-
broids (SMgroup)while 45 had intramural
fibroids (IM group), 11 had subserosal fi-
broids (SS group), 42 had a mix of submu-
cosal-intramural (SM-IM group) and 31
patients had amix of intramural-subserosal
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Casini 2006 (Continued)
fibroids (IM-SS group).”
Quote: “Out of 181 women, 68 become
pregnant.”
Comment: low risk for attrition bias.
Selective reporting (reporting bias) High risk All specified outcomes reported in the re-
sults section. Nevertheless, the published
report failed to include results for the live
birth rate, which was the primary outcome
of interest that would be expected to have
been reported for a trial on fertility treat-
ment conducted over a 7-year period
Other bias Unclear risk The mean ages and duration of infertility
in the intervention and control group of
women with submucous fibroids were not
reported.No further clarification by the au-
thors was obtained
It was unclear whether there might have
been imbalance in the baseline characteris-
tics between the comparison groups
Failure to do a hysteroscopy in all women
to confirm the position of the ultrasonically
detected fibroids could have caused infor-
mation bias
Pérez-Medina 2005
Methods Parallel-group, randomised, controlled, single-centre trial
Power analysis performed. To detect an expected difference in pregnancy rate between
the intervention and control group of 15% at a level of 0.05 with a power of 80%,
a sample size of 200 women (i.e. 100 women per group) was required. From 2800
women attending the centre, 452 women fulfilling the inclusion criteria were selected;
215 women were randomised (107 women in the intervention group and 108 women in
the control group). Data on outcomes of 204 women were available for analysis (101 in
the intervention group and 103 in the control group). This study had therefore adequate
statistical power to detect a difference between the comparison groups if really present
Approved by the hospital’s ethics committee.
No source of funding or conflict of interest reported.
Participants Country: Spain
Setting: infertility unit of an university tertiary hospital in the Spanish capital Madrid
Population: women with unexplained, male or female factor infertility for ≥ 24 months
bound to undergo IUI with a sonographic diagnosis of endometrial polyps
Unexplained infertility was diagnosed in women with normal ovulatory cycles, semen
analysis, HSG and postcoital testing. Male factor infertility was diagnosed if 2 semen
analyses obtained ≥ 1 month apart were subnormal according to the WHO criteria.
Female factor infertility was diagnosed in women with ovulatory dysfunction, cervical
factor or endometriosis
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Pérez-Medina 2005 (Continued)
Type of subfertility: primary subfertility (correspondence with study authors)
Mean age: treatment group: 30.8 years (range 26.7 to 34.9); control group: 30.9 years
(range 26.5 to 35.3)
Number recruited: 452 women
Number randomised: 215 women
Inclusion criteria: women with≥ 24 months of subfertility with a sonographic diagnosis
of endometrial polyps bound to undergo IUI for unexplained, male or female factor
infertility
Exclusion criteria: women aged > 39 years, anovulation, azoospermia, uncorrected tubal
disease or previous unsuccessful use of recombinant FSH
Duration of the study: 50 months; conducted January 2000 to February 2004
Interventions 1 surgeon (the first author of the study) performed all hysteroscopic procedures by
intention in an outpatient clinic setting under local anaesthesia
• Hysteroscopic polypectomy using a 5.5 mm continuous flow office hysteroscope
with a 1.5 mm scissors and forceps (107 women)
• Diagnostic hysteroscopy using a 5.5 mm continuous flow office hysteroscope and
polyp biopsy (108 women)
Duration: women were scheduled to receive 4 cycles of IUI with subcutaneous injection
of recombinant FSH 50 IU daily from the 3rd day, and the first IUI was planned for 3
cycles after hysteroscopy in both groups. 4 IUI cycles were attempted before finishing
the trial
Outcomes Primary: quote: “We studied the crude pregnancy rate in both groups”
Comment: clinical pregnancy; crude pregnancy was defined by the study authors as
follows: “the presence of a gestational sac on ultrasound” (correspondence with the study
authors)
Secondary: time-to-pregnancy and influence of the size of the endometrial polyps on the
pregnancy rate
Notes All study data were obtained in personal communication from the study authors
1. Quote: “Patients underwent a complete infertility evaluation that included TVUS
in the early proliferative phase, basal body temperature recording to assess ovulation,
postcoital test (PCT),HSG, semen analysis and, in somepatients, diagnostic laparoscopy.
”
Comment: according to correspondence with the first author, the aim of the laparoscopy
was exclusively diagnostic in the evaluation of cases of unexplained infertility of unknown
origin. If tubal pathology was detected by laparoscopy, the participant was excluded
from randomisation. The numbers of women undergoing a laparoscopy were balanced
between the 2 comparison groups
2. This study performed IUI for various indications: male factor (21%), cervical factor
(11%), endometriosis (11%), or unexplained subfertility (49%) and ovulation disorder
(33%). Anovulation was reported in the methods section as an exclusion criterion. The
study authors defined ovulation disorder as follows: quote: “A combination of irregular
menstrual cycles with multicystic ovaries on TVUS and basal gonadotrophin measure-
ments within the normal range” (correspondence with the first study author). Comment:
in everyday clinical practice ovulation disorder is not an indication for IUI by itself
3. Data on the number or the localisation of the polyps could not be retrieved since the
first author no longer works in the university hospital
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4. Data on the size of the polyps in the control group could not be obtained for similar
reasons as note 3
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomised to one
of the two groups with use of an opaque en-
velope technique, with assignment deter-
mined by a computerized random number
table.”
Quote: “Subjectswere randomised into one
of two groups in a 1:1 ratio using a re-
stricted randomisation.”
Comment: probably done, but using sim-
ple randomisation, with an equal alloca-
tion ratio, by referring to a table of random
numbers generated by a computer
Allocation concealment (selection bias) Low risk Quote: “Patients were randomised to one
of the two groups with use of an opaque en-
velope technique, with assignment deter-
mined by a computerized random number
table.”
Comment: sequentially
numbered, opaque, sealed envelopes were
used according to correspondence with the
first author; probably done
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Method not stated: no further clarification
obtained from the study authors
Comment: not applicable as this is a surgi-
cal study with unequivocal outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Method not stated: no further clarification
obtained from the study authors
Comment: not applicable as this is a surgi-
cal study with unequivocal outcomes
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “11 patients were lost from the
study, 6 in the study group (3 lost to fol-
low-up, 2 pathologic reports of submucosal
myoma and 1 in whom the polyp was not
confirmed) and 5 in the control group (1
lost to follow-up, 2 in whom the polyp was
not confirmed and 2 pathologic reports of
myoma).”
Comment: missing outcome data were bal-
39Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pérez-Medina 2005 (Continued)
anced in numbers across the comparison
groups, with similar reasons for missing
data across groups
Selective reporting (reporting bias) High risk All specified outcomes reported in the re-
sults section. The final study report never-
theless failed to include results for the live
birth rate, which is the primary outcome
of interest expected for a trial on fertility
treatment conducted over a 4-year period.
Data on the outcomes live birth and mis-
carriage were not available since most the
majority of randomised women were re-
ferred by gynaecologists from outside the
tertiary university hospital and were re-
ferred back when pregnant for further fol-
low-up by the referring gynaecologist. No
clarification could be obtained for the lack
of data on hysteroscopic complications
Other bias Low risk No evidence for imbalance in the baseline
characteristics.
CI: confidence interval; FSH: follicle-stimulating hormone; HSG: hysterosalpingography; IU: international units; IUI: intrauterine
insemination; TVUS: transvaginal ultrasound; WHO: World Health Organization.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abiri 2014 Not addressing the research questions described in the protocol
RCT in women with no suspected major uterine cavity abnormalities undergoing a first IVF treatment
cycle
Abu Rafea 2013 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing intrauterine balloon stenting vs no stenting following hystero-
scopic treatment for septate uterus
Acunzo 2003 Not addressing the research questions described in the protocol
Parallel-group randomised trial studying the efficacy of hyaluronic acid gel in preventing the development of
intrauterine adhesions following hysteroscopic adhesiolysis. Mixed population of women with intrauterine
adhesions, presenting with subfertility or other gynaecological complaints. Primary outcome: adhesion
scores
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Aghahosseini 2012 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing hysteroscopy prior to a subsequent IVF attempt vs immediate
IVF without prior hysteroscopy conducted in women with ≥ 2 failed IVF cycles with unsuspected or no
uterine cavity abnormalities. Main outcomes: biochemical pregnancy, clinical pregnancy and delivery rates
Aghajanova 2018 Not addressing the research questions described in the protocol
Randomised controlled open pilot clinical trial studying the efficacy of the intrauterine infusion of autolo-
gous platelet rich plasma vs saline infusion after operative hysteroscopy for the management of moderate-
to-severe Asherman’s syndrome
Aleyassin 2017 Not addressing the research questions described in the protocol
RCT studying the effectiveness of routine hysteroscopy compared to no prior hysteroscopy in women with
normal transvaginal ultrasound and HSG before the first ICSI treatment cycle
Amer 2010 Not addressing the research questions described in the protocol
Parallel-group randomised trial in subfertile women comparing the application of amnion graft, either
fresh or dried to an intrauterine balloon vs the application of an intrauterine balloon without amnion
graft as an adjunctive procedure after the hysteroscopic lysis of severe intrauterine adhesions, diagnosed at
clinic hysteroscopy in women with infertility with or without menstrual disorders as the primary symptom.
Outcomes: improvement in adhesion grade, improvement in menstruation, increased uterine length at
sounding, complications and reproductive outcome
Basma 2013 Not addressing the research questions described in the protocol
Women with detectable uterine pathology by ultrasound were excluded from participating in the trial
aiming to study the effectiveness of hysteroscopy before a first trial ICSI
Cao 2018 Not addressing the research questions described in the protocol
Systematic review including clinical trials of hysteroscopy with or without endometrial biopsy in women
with recurrent implantation failure and no suspected intrauterine lesions
Chen 2017 Not addressing the research questions described in the protocol
RCT investigating the effects of mindfulness-based stress reduction on anxiety, depression and quality of
life in women with intrauterine adhesions
Clark 2015 Not addressing the research questions described in the protocol
The target population included women with abnormal uterine bleeding and hysteroscopically diagnosed
uterine polyps
Colacurci 2007 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing 2 different surgical techniques for metroplasty: operative hys-
teroscopy using the resectoscope with a unipolar knife vs the Versapoint device.Mixed population of women
with septate uterus and a history of recurrent miscarriage or primary subfertility. Outcomes: operative pa-
rameters, complications, need for a second intervention and reproductive outcome parameters
Darwish 2009 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing extended sectioning by resectoscopy vs sequential cold knife
excision for treating a complete utero-cervicovaginal septum in amixed population of womenwith infertility
or pregnancy loss. Main outcomes: operating time, perioperative bleeding, complications, reproductive
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outcome, and participant and husband satisfaction
De Angelis 2010 Study on the effectiveness of hysteroscopic metroplasty for small septate uterus in women with repeated
IVF implantation failure. Although denoted by the authors as the first prospective randomised controlled
study on this subject, the trial did not use a valid random sequence generation
Quote: “These patients, once informed about the situation, were randomly allocated, depending on their
personal decision ...”
De Iaco 2003 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing the application of hyaluronan derivative gel (Hyalobarrier gel)
after hysteroscopic surgery vs surgical treatment alone in women aged 18-65 years, with gynaecological
conditions other than subfertility. Primary outcome: adhesion score at second-look hysteroscopy
Demirol 2004 Not addressing the research questions described in the protocol
Parallel-group randomised comparison between clinic hysteroscopy prior to a subsequent IVF attempt or
immediate IVF without prior clinic hysteroscopy conducted in women with ≥ 2 failed IVF cycles with
unsuspected or no uterine cavity abnormalities. Outcomes: number of oocytes retrieved, fertilisation rate,
number of embryos transferred, first trimester miscarriage and clinical pregnancy rates
Di Florio 2013 Not addressing the research questions described in the protocol
RCT comparing the new 16 Fr mini-resectoscope with the traditional 22 Fr resectoscope and Bettocchi 15
Fr hysteroscope for the treatment of uterine cavitary lesions
Di Spiezio Sardo 2011 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing the use of Intercoat absorbable adhesion barrier gel vs no ad-
hesion barrier after hysteroscopic synechiolysis in a mixed population of women with infertility or other
gynaecological conditions. Primary outcomes: incidence of de novo intrauterine adhesions, adhesion scores
and patency of the internal uterine ostium
El-Khayat 2015 Not addressing the research questions described in the protocol
RCT evaluating the role of endometrial injury in the cycle preceding ovarian stimulation for IUI cycle on
the clinical pregnancy rate
El-Nashar 2011 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing diagnostic hysteroscopy with directed biopsy or hysteroscopic
treatment of unsuspected uterine cavity abnormalities (or both) vs no hysteroscopy in women with primary
infertility treated with ICSI. Primary outcome: clinical pregnancy
El-Toukhy 2009 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing hysteroscopy vs no hysteroscopy in women with recurrent im-
plantation failure with IVF. Status: completed
Elsetohy 2015 Not addressing the research questions described in the protocol
Parallel-group randomised trial aimed at assessing the role of using clinic hysteroscopy as a routine investi-
gation in improving ICSI pregnancy rates in 2 groups of infertile women with no abnormality detected on
transvaginal ultrasonographic examination
Fatemi 2007 Not addressing the PICO research question of this Cochrane Review
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Fuchs 2014 Not addressing the PICO research question of this Cochrane review
RCT evaluating the safety and effectiveness of Oxiplex/AP gel (Intercoat) in reducing intrauterine adhesion
formation after hysteroscopic treatment because of retained products of conception
Gan 2017 Not addressing the PICO research question of this Cochrane Review
RCT studying the efficacy of freeze-dried amnion graft for prevention of intrauterine adhesion reformation
after hysteroscopic adhesiolysis
Gao 2013 Observational non-randomised study on the effectiveness of hysteroscopy in women with repeated implan-
tation failure
Guida 2004 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing hysteroscopic surgery for the removal of polyps, fibroids or septa
followed by the application of auto-cross linked hyaluronic acid gel vs hysteroscopic surgery without the
adhesion barrier in a mixed population of women with subfertility and other gynaecological symptoms
associated with endometrial polyps, submucous fibroids or septa. Main outcomes: rates of adhesion forma-
tion and adhesion scores
Guo 2017 Not addressing the research questions described in the protocol
Prospective, randomised, controlled trial to evaluate the efficacy of different doses of oestrogen treatment (2
mg and 6 mg daily) after hysteroscopic adhesiolysis in women with moderate-to-severe adhesion according
to the American Fertility Society classification of intrauterine adhesions
Hamerlynck 2015 Not addressing the research questions described in the protocol
Multicentre, open-label, randomised, controlled trial comparing hysteroscopic morcellation with bipolar
resectoscopy for removal of endometrial polyps, in terms of procedure time, peri- and postoperative adverse
events, tissue availability and short-term effectiveness
Hanstede 2016 Not addressing the research questions described in the protocol
Single-blind RCT assessing whether exogenous hormone administration starting immediately after a suc-
cessful hysteroscopic adhesiolysis, in women with Asherman’s syndrome may reduce the incidence of spon-
taneous recurrence of adhesions more than the endogenic production of hormones
Hare 2013 Not addressing the research questions described in the protocol
Randomised controlled study examining the effect of scratching in a normal visually and histologically
endometrium. Women with uterine pathology were excluded before or during clinic hysteroscopy
Javidan 2017 Not addressing the research questions described in the protocol
Single-blind RCT to assess the outcomes of surgery in a group of women who were randomly submitted
to preoperative gonadotropin-releasing hormone agonists in comparison with women who received no
medication
Kamel 2014 Not addressing the research questions described in the protocol
Randomised controlled study to compare mechanical (cold scissor) vs electrosurgical metroplasty (bipolar
twizzle) in terms of feasibility and pain scoring during ambulatory-based hysteroscopic metroplasty for
short, narrow-based uterine septa
43Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Lara-Dominguez 2016 Not addressing the research questions described in the protocol
RCTcomparing the resectionof endometrial polypswith 2different devices: theVersapoint bipolar electrode
and the diode laser
Lieng 2010a Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing transcervical resection by hysteroscopy of endometrial polyps
suspected on TVUS and SIS vs observation for 6 months. The study population included premenopausal
women with bleeding problems associated with endometrial polyps. The aim of the trial was to study the
clinical effectiveness of transcervical resection of endometrial polyps for the outcome periodic blood loss.
Women wishing to become pregnant were excluded from the trial. Primary outcome: periodic blood loss
measured by the Pictorial Blood Assessment Chart
Lin 2014 Not addressing the research questions described in the protocol
Randomised trial comparing the efficacy of intrauterine balloon and intrauterine contraceptive device in
the prevention of adhesion reformation following hysteroscopic adhesiolysis
Liu 2016 Not addressing the research questions described in the protocol
RCT randomly comparing oestradiol valerate (Progynova) 3 mg or 9 mg per diet before surgery or no
hormonal treatment before transcervical resection of adhesions
Mohammed 2014 Comparative non-randomised study on the value of hysteroscopy prior to IVF/ICSI
Moramezi 2012 Not addressing the research questions described in the protocol
RCT studying the effectiveness of hysteroscopy before IUI on reproductive outcome in infertile women
with no suspected intrauterine lesions during baseline fertility assessment
Muzii 2007 Not addressing the research questions described in the protocol
Parallel-group randomised trial in women aged 18-75 years comparing operative hysteroscopy using the
monopolar resectoscope vs hysteroscopic bipolar electrode excision for the treatment of endometrial polyps.
Outcomes: operating times, difficulty of the operation, surgeon satisfaction with the procedure, complica-
tions, postoperative pain and participant satisfaction
Muzii 2017 Not addressing the research questions described in the protocol
Multicentric randomised trial in 180 women affected by endometrial hyperplasia, myomas or endometrial
polyps undergoing operative hysteroscopy comparing cefazolin 2 g intravenously 30 minutes prior to the
procedure vs no antibiotic treatment
Nappi 2013 Not addressing the research questions described in the protocol
Double-blind, randomised, placebo-controlled study to assess the incidence of infectious complications and
the protective effect of antibiotic administrationduring operative hysteroscopic procedures in a clinic setting.
1046 consecutively enrolled women with intrauterine lesions were randomly allocated to the intervention
group (523 participants administered cefazolin 1 g intramuscularly) and the control group (523 participants
administered with 10 mL of isotonic sodium chloride solution), and treated in clinic setting by operative
hysteroscopy for endometrial polypectomy, uterine septa, submucosal myomas and intrauterine adhesions
Pabuccu 2008 Quasi-randomised trial comparing early second-look clinic hysteroscopic adhesiolysis after hysteroscopic
adhesiolysis and IUD insertion vs no early second-look operative hysteroscopy in subfertile women with
intrauterine adhesions. Themethod of sequence generation was based on alternation: women were allocated
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to the intervention or control groups based on their study entry. Main outcomes: pregnancy and live birth
rate
Parsanezhad 2006 Not addressing the research questions described in the protocol
Parallel-group randomised trial in a mixed study population of women with a history of pregnancy wastage
or infertility and an associated complete uterine septum comparing metroplasty with complete section of
the cervical septum vs metroplasty with preservation of the cervical septum. Outcomes: operating time,
distending media deficit, total distending media used, intraoperative bleeding, complications and repro-
ductive outcome
Paz 2014 Not addressing the research questions described in the protocol
Randomised, double-blind, controlled trial to evaluate the efficacy and safety of Intercoat (Oxiplex/APGel)
in preventing intrauterine adhesions after operative hysteroscopy
Rama Raju 2006 Not addressing the research questions described in the protocol
Parallel-group randomised trial conducted in women with ≥ 2 failed IVF cycles with unsuspected or no
uterine cavity abnormalities comparing clinic hysteroscopy prior to a subsequent IVF attempt or immediate
IVF without prior hysteroscopy. Outcomes: number of oocytes retrieved, fertilisation rate, number of
embryos transferred and clinical pregnancy rates
Revel 2011 Not addressing the research questions described in the protocol
Parallel-group RCT assessing the safety of hyaluronic acid gel to prevent intrauterine adhesions in hystero-
scopic surgery
Roy 2014 Not addressing the research questions described in the protocol
RCT to evaluate the efficacy of oestrogen in preventing intrauterine adhesions following hysteroscopic
septal resection and to investigate its effect on reproductive outcome
Roy 2015 Not addressing the research questions described in the protocol
RCT to compare the operation and reproductive outcome of hysteroscopic septal resection using unipolar
resectoscope vs bipolar resectoscope
Roy 2017 Not addressing the research questions described in the protocol
Randomised, prospective, parallel, comparative, single-blinded study comparing the operative and repro-
ductive outcome of hysteroscopic myomectomy using unipolar resectoscope vs bipolar resectoscope in
women with infertility and menorrhagia
Rubino 2015 Not addressing the research questions described in the protocol
Randomised, prospective, comparative setting clinical trial to examine efficacy of hysteroscopic removal of
polyps and myomas on health-related quality of life and symptom severity at 1-year postprocedure in a
clinic vs ambulatory surgical centre
Shawki 2012 Not addressing the research questions described in the protocol
Parallel-group randomised trial conducted to determine the incidence of unsuspected uterine cavity ab-
normalities detected by clinic hysteroscopy in women before ICSI treatment compared to ICSI without
prior hysteroscopy. Main outcomes: incidence of unsuspected uterine abnormalities, and implantation and
clinical pregnancy rates
45Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Shokeir 2010 Published report describing a parallel-group randomised trial comparing hysteroscopic myomectomy vs di-
agnostic hysteroscopy and biopsy in women with otherwise unexplained primary infertility and submucous
fibroids. Primary outcome: clinical pregnancy rates
Quote from Fertility and Sterility searched on 16 January 2012: “This article has been retracted at the request
of the editor as it duplicates parts of a paper that had already appeared in Hum. Reprod., 20 (2005) 1632-
1635, DOI:10.1093/humrep/deh822.”
Smit 2015 Not addressing the research questions described in the protocol
RCT assessing the interobserver agreement among gynaecologists who were randomised into 2 groups: 1
group received diagnostic criteria for a septate uterus before assessment of videos, whereas the other group
assessed the recordings without instruction
Smit 2016 Not addressing the research questions described in the protocol
Pragmatic, multicentre, RCT in women with a normal TVUS of the uterine cavity and no previous hys-
teroscopy who were scheduled for their first IVF treatment randomly comparing treatment with hys-
teroscopy of detected intracavitary abnormalities before starting IVF vs immediate start of the IVF treat-
ment
Smith 2014 Not addressing the research questions described in the protocol
Multicentre, single-blind, randomised, controlled trial to evaluate whether hysteroscopic morcellation or
bipolar electrosurgical resection was more favourable for removing endometrial polyps in a clinic setting in
terms of feasibility, speed, pain and acceptability
Sohrabvand 2012 Not addressing the research questions described in the protocol
Parallel-group RCT to assess the effectiveness of diagnostic hysteroscopy in women prior to IVF/IICSI.
The study population included women with a normal hysterosonography and normal vaginal ultrasound
during the past 12 months
Tonguc 2010 Not addressing the research questions described in the protocol
Parallel-group randomised study comparing hysteroscopic lysis of intrauterine adhesions with or with-
out adjunctive therapy (cyclical hormone replacement therapy alone or intrauterine device alone or both
cotreatments combined) after hysteroscopic metroplasty in a mixed population of women with subfertility
or recurrent miscarriage (or both). Main outcomes: incidence of de novo adhesion formation and ongoing
pregnancy rate
Trnini -Pjevi 2011 Clinical controlled trial on the effectiveness of hysteroscopy prior to IVF; no random sequence generation
van Dongen 2008 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing the hysteroscopic removal of polyps or fibroids by conventional
hysteroscopy using a resectoscope vs hysteroscopic morcellation in a mixed population of women with
infertility or other gynaecological conditions. Outcomes: mean number of insertions into the uterine cavity
and mean operating time
Vercellini 1993 Not addressing the research questions described in the protocol
Parallel-group randomised comparing metroplasty using the resectoscope vs microscissors for treating uter-
ine septum in women with repeated miscarriage. Outcomes: mean operating time, mean amount of dis-
tension medium used and complications
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Weiss 2005 Not addressing the research questions described in the protocol
Parallel-groupRCTtodeterminewhether performing curettage themonth prior to embryo transfer increases
the chance of embryo implantation
Xiao 2015 Not addressing the research questions described in the protocol
Prospective, randomised, double-blind, controlled clinical trial assessing the efficacy and safety of auto-
crosslinked hyaluronic acid gel for preventing intrauterine adhesions after hysteroscopic adhesiolysis
Youssef 2013 Not addressing the research questions described in the protocol
Parallel-group randomised trial comparing 2 different surgical techniques for metroplasty: resectoscopy with
monopolar knife vs small-diameter hysteroscopy fitted with a 5 Fr reusable bipolar electrode. Outcomes:
pregnancy, miscarriage and live birth rates
HSG: hysterosalpingography; ICSI: intracytoplasmic sperm injection; IUD: intrauterine device; IUI: intrauterine insemination; IVF:
in vitro fertilisation; PICO: Participants, Interventions, Comparisons and Outcomes; RCT: randomised controlled trial; SIS: saline
infusion sonography; TVUS: transvaginal ultrasound.
Characteristics of ongoing studies [ordered by study ID]
SEPTUM trial
Trial name or title Assessment of hysteroscopic metroplasty in women with a uterine septum and a history of miscarriage: a
randomised controlled trial - SEPTUM
Methods Pilot multicentre randomised controlled trial to assess feasibility for a larger adequately powered trial
Participants Women with septate uteri, history of miscarriage or preterm birth, or infertility
Interventions Intervention: hysteroscopic septal resection
Comparator: no intervention
Outcomes Primary outcome
• Live birth surviving until discharge from hospital
Secondary outcomes
• Uterine perforation
• Fluid overload
• Endometritis
• Bleeding
• Incomplete resection
• Synechiae or adhesions
• Clinical pregnancy rate
• Miscarriage (first or second trimester)
• Premature delivery (< 34 weeks and < 37 weeks)
• Ectopic pregnancy
• Uterine rupture
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• Delivery (vaginal, elective or emergency)
• Postpartum haemorrhage (1500 mL)
• Placenta praevia
• Morbidly adherent placenta
Starting date 9 December 2014
Contact information Dr Matthew Prior
Subspecialty Registrar in Reproductive Medicine and Surgery
Newcastle Fertility Centre
email: matt@matthewprior.com
mobile: +44 7817 627 712
Notes Quote: “The trial is ongoing but closed to recruitment due to feasibility issues with recruitment. Six partici-
pants were recruited and will be followed up for 24 months post intervention.”
TRUST trial
Trial name or title TRUST - The Randomised Uterine Septum Transsection trial
Methods Multicentre, parallel-group, randomised controlled trial. No masking/blinding
Participants Inclusion criteria
• Women with women with subfertility or preterm birth ≥ 2 preceding miscarriages before 20 weeks of
gestational age and a septate uterus
• Diagnosis of a septate uterus
• Active wish to conceive.
Exclusion criteria
• Prior randomisation in the TRUST
• Contraindications for surgery
Interventions Intervention: hysteroscopic metroplasty
Comparator: no surgical resection
Outcomes Primary outcome
• Live birth rate (defined as a live birth after 24 weeks of gestational age)
Secondary outcomes
• Complications following hysteroscopic metroplasty
• Obstetrical complications
Starting date 1 October 2008
Contact information Dr JFW Rikken
Notes 4 May 2018: inclusion of 63rd participant; targeted sample size = 68
Trial website: www.studies-obsgyn.nl/trust/
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D A T A A N D A N A L Y S E S
Comparison 1. Operative hysteroscopy versus control in women with otherwise unexplained subfertility and
suspected major uterine cavity abnormalities
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Clinical pregnancy 1 94 Odds Ratio (M-H, Fixed, 95% CI) 2.44 [0.97, 6.17]
1.1 Removal of submucous
fibroids only vs no surgery
1 52 Odds Ratio (M-H, Fixed, 95% CI) 2.04 [0.62, 6.66]
1.2 Removal of mixed
submucous-intramural fibroids
vs no surgery
1 42 Odds Ratio (M-H, Fixed, 95% CI) 3.24 [0.72, 14.57]
2 Adverse events: miscarriage 1 94 Odds Ratio (M-H, Fixed, 95% CI) 1.54 [0.47, 5.00]
2.1 Removal of submucous
fibroids only vs no surgery
1 52 Odds Ratio (M-H, Fixed, 95% CI) 1.27 [0.27, 5.97]
2.2 Removal of mixed
submucous-intramural fibroids
vs no surgery
1 42 Odds Ratio (M-H, Fixed, 95% CI) 2.0 [0.32, 12.33]
Comparison 2. Operative hysteroscopy versus control in women undergoing medically assisted reproduction with
suspected major uterine cavity abnormalities
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Clinical pregnancy 1 204 Odds Ratio (M-H, Fixed, 95% CI) 4.41 [2.45, 7.96]
1.1 Hysteroscopic
polypectomy vs diagnostic
hysteroscopy and biopsy
only prior to intrauterine
insemination
1 204 Odds Ratio (M-H, Fixed, 95% CI) 4.41 [2.45, 7.96]
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Analysis 1.1. Comparison 1 Operative hysteroscopy versus control in women with otherwise unexplained
subfertility and suspected major uterine cavity abnormalities, Outcome 1 Clinical pregnancy.
Review: Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
Comparison: 1 Operative hysteroscopy versus control in women with otherwise unexplained subfertility and suspected major uterine cavity abnormalities
Outcome: 1 Clinical pregnancy
Study or subgroup
Operative
hys-
teroscopy No surgery Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Removal of submucous fibroids only vs no surgery
Casini 2006 (1) 13/30 6/22 66.2 % 2.04 [ 0.62, 6.66 ]
Subtotal (95% CI) 30 22 66.2 % 2.04 [ 0.62, 6.66 ]
Total events: 13 (Operative hysteroscopy), 6 (No surgery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.18 (P = 0.24)
2 Removal of mixed submucous-intramural fibroids vs no surgery
Casini 2006 (2) 8/22 3/20 33.8 % 3.24 [ 0.72, 14.57 ]
Subtotal (95% CI) 22 20 33.8 % 3.24 [ 0.72, 14.57 ]
Total events: 8 (Operative hysteroscopy), 3 (No surgery)
Heterogeneity: not applicable
Test for overall effect: Z = 1.53 (P = 0.13)
Total (95% CI) 52 42 100.0 % 2.44 [ 0.97, 6.17 ]
Total events: 21 (Operative hysteroscopy), 9 (No surgery)
Heterogeneity: Chi2 = 0.22, df = 1 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.059)
Test for subgroup differences: Chi2 = 0.22, df = 1 (P = 0.64), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours no surgery Favours oper hysteroscopy
(1) The intervention was the hysteroscopic removal of fibroids. The comparison arm was no surgical removal of fibroids.
(2) The intervention was the hysteroscopic removal of fibroids. The comparison arm was no surgical removal of fibroids.
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Analysis 1.2. Comparison 1 Operative hysteroscopy versus control in women with otherwise unexplained
subfertility and suspected major uterine cavity abnormalities, Outcome 2 Adverse events: miscarriage.
Review: Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
Comparison: 1 Operative hysteroscopy versus control in women with otherwise unexplained subfertility and suspected major uterine cavity abnormalities
Outcome: 2 Adverse events: miscarriage
Study or subgroup
Operative
hys-
teroscopy No surgery Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Removal of submucous fibroids only vs no surgery
Casini 2006 (1) 5/30 3/22 62.7 % 1.27 [ 0.27, 5.97 ]
Subtotal (95% CI) 30 22 62.7 % 1.27 [ 0.27, 5.97 ]
Total events: 5 (Operative hysteroscopy), 3 (No surgery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.77)
2 Removal of mixed submucous-intramural fibroids vs no surgery
Casini 2006 (2) 4/22 2/20 37.3 % 2.00 [ 0.32, 12.33 ]
Subtotal (95% CI) 22 20 37.3 % 2.00 [ 0.32, 12.33 ]
Total events: 4 (Operative hysteroscopy), 2 (No surgery)
Heterogeneity: not applicable
Test for overall effect: Z = 0.75 (P = 0.46)
Total (95% CI) 52 42 100.0 % 1.54 [ 0.47, 5.00 ]
Total events: 9 (Operative hysteroscopy), 5 (No surgery)
Heterogeneity: Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Chi2 = 0.14, df = 1 (P = 0.71), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours no surgery Favours oper hysteroscopy
(1) The intervention was the hysteroscopic removal of fibroids. The comparison arm was no surgical removal of fibroids.
(2) The intervention was the hysteroscopic removal of fibroids. The comparison arm was no surgical removal of fibroids.
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Analysis 2.1. Comparison 2 Operative hysteroscopy versus control in women undergoing medically assisted
reproduction with suspected major uterine cavity abnormalities, Outcome 1 Clinical pregnancy.
Review: Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
Comparison: 2 Operative hysteroscopy versus control in women undergoing medically assisted reproduction with suspected major uterine cavity abnormalities
Outcome: 1 Clinical pregnancy
Study or subgroup
Operative
hys-
teroscopy No surgery Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Hysteroscopic polypectomy vs diagnostic hysteroscopy and biopsy only prior to intrauterine insemination
P rez-Medina 2005 (1) 64/101 29/103 100.0 % 4.41 [ 2.45, 7.96 ]
Total (95% CI) 101 103 100.0 % 4.41 [ 2.45, 7.96 ]
Total events: 64 (Operative hysteroscopy), 29 (No surgery)
Heterogeneity: not applicable
Test for overall effect: Z = 4.93 (P < 0.00001)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours no surgery Favours oper hysteroscopy
(1) The intervention was the hysteroscopic removal of polyps. The comparison arm was simple diagnostic hysteroscopy with biopsy.
A D D I T I O N A L T A B L E S
Table 1. Effect of polyp size on clinical pregnancy rates in the intervention group
Polyp size Clinical pregnancya Clinical pregnancy rate (95% CI)b
< 5 mm 19/25 76% (72% to 80%)
5-10 mm 18/32 56% (53% to 59%)
11-20 mm 16/26 61% (58% to 65%)
> 20 mm 11/18 61% (58% to 64%)
CI: confidence interval.
aClinical pregnancy is definedby a pregnancy diagnosed by ultrasound visualisation of at least one gestational sac perwoman randomised.
bNo significant difference was found for the clinical pregnancy rates between the 4 subgroups (P = 0.32).
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Table 2. GRADE evidence profile - unexplained subfertility and submucous fibroids
Quality assessment
Submucous fibroids and unexplained subfertility
No of studies Design Limitations Inconsistency Indirectness Imprecision Other considerations
Clinical pregnancy (follow-up 1 year; ultrasounda )
1 RCT Very seriousb Not serious Not indirectness Seriousc None
Miscarriage (follow-up 1 year; ultrasoundd )
1 RCT Very seriousb Not serious Not serious Seriousc None
aA clinical pregnancy was defined by the visualisation of an embryo with cardiac activity at six to seven weeks’ gestational age.
bUnclear allocation concealment and high risk of selective outcome reporting.
cWide confidence intervals.
dMiscarriage was defined by the clinical loss of an intrauterine pregnancy between the 7th and 12th weeks of gestation.
Table 3. GRADE evidence profile - endometrial polyps prior to intrauterine insemination
Quality assessment
Endometrial polyps prior to gonadotropin and IUI treatment
No of studies Design Limitations Inconsistency Indirectness Imprecision Other considerations
Clinical pregnancy (follow-up 4 IUI cycles; ultrasounda )
1 RCT Seriousb Not serious Not serious Not serious None
IUI: intrauterine insemination; RCT: randomised controlled trial.
aClinical pregnancy was defined by the presence of at least one gestational sac on ultrasound.
bThere was high risk for selective outcome reporting bias.
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A P P E N D I C E S
Appendix 1. The Cochrane Gynaecology and Fertility Group (CGFG) specialised register search
strategy
Searched 16 April 2018
PROCITE Platform
Keywords CONTAINS “hysteroscopic ”or “hysteroscopy” or “hysteroscope” or “endoscopy” or Title CONTAINS “hysteroscopic ”or
“hysteroscopy” or “hysteroscope” or “endoscopy”
AND
Keywords CONTAINS “subfertility” or “subfertility-Female” or “infertility” or “IVF” or “ICSI” or “IUI” or “in vitro fertilisation”
or “in vitro fertilization” or “Intrauterine Insemination” or “artificial insemination” or “assisted conception” or “assisted reproduction
techniques” or “myoma” or “myomas” or “myomectomy” or “septate uterus” or “polypectomy” or “polyp removal” or “polyps”
or “adhesiolysis” or “adhesion” or “adhesions” or “synechiotomy” or “Leiomyoma” or “leiomyomata” or “fibroids” or “Asherman’s
Syndrome” or “uterine septa” or “uterine septum” or “uterine disease” or “uterine leiomyomas” or “uterine malformation” or “Uterine
Neoplasms” or “uterine polyps” or “metroplasty” or “intrauterine adhesions” or “fibroid” or “fibroids” or Title CONTAINS “subfertility”
or “assisted reproduction techniques” or “myoma” or “myomas” or “myomectomy” or “septate uterus” or “polypectomy” or “metroplasty”
or “intrauterine adhesions” or “fibroid” or “fibroids”
272 records
Appendix 2. CENTRAL Register of Studies Online (CRSO) search strategy
Searched 16 April 2018
Web Platform
#1 MESH DESCRIPTOR Hysteroscopy EXPLODE ALL TREES 349
#2 Hysteroscop*:TI,AB,KY 902
#3 endoscop*:TI,AB,KY 17242
#4 #1 OR #2 OR #3 18070
#5 MESH DESCRIPTOR Infertility, Female EXPLODE ALL TREES 1127
#6 (subfertil* or infertil*):TI,AB,KY 5049
#7 MESH DESCRIPTOR Reproductive Techniques, Assisted EXPLODE ALL TREES 2919
#8 (IVF or ICSI):TI,AB,KY 4175
#9 (artificial insemination):TI,AB,KY 182
#10 (assisted conception):TI,AB,KY 86
#11 (in vitro fertili*):TI,AB,KY 2233
#12 (intracytoplasmic sperm):TI,AB,KY 1373
#13 (intrauterine insemination):TI,AB,KY 734
#14 MESH DESCRIPTOR Leiomyoma EXPLODE ALL TREES 449
#15 MESH DESCRIPTOR myoma EXPLODE ALL TREES 21
#16 (myoma* or myomectom*):TI,AB,KY 946
#17 Leiomyoma*:TI,AB,KY 631
#18 (sept* uter*):TI,AB,KY 19
#19 (?Uter* adj4 polyp*):TI,AB,KY 38
#20 (Endometri* adj4 polyp*):TI,AB,KY 172
#21 (adhesiolysis or septoplast* or metroplast*):TI,AB,KY 381
#22 MESH DESCRIPTOR Tissue Adhesions EXPLODE ALL TREES 342
#23 (remov* adj2 adhesion*):TI,AB,KY or (?intrauter* adj2 adhesion*):TI,AB,KY 62
#24 synech*:TI,AB,KY 270
#25 (uter* adj2 malform*):TI,AB,KY 38
#26 (Uter* adj4 Neoplasm*):TI,AB,KY 2161
#27 (uter* adj4 abnormalit*):TI,AB,KY 99
#28 fibroid*:TI,AB,KY 557
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#29 #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #
20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 12761
#30 #4 AND #29 623
Appendix 3. MEDLINE search strategy
Searched from 1946 to 16 April 2018
OVID Platform
1 exp Hysteroscopy/ (4330)
2 Hysteroscop$.tw. (6123)
3 Uteroscop$.tw. (13)
4 endoscop$.tw. (179897)
5 Endoscopy/ (47569)
6 or/1-5 (201815)
7 exp Infertility/ (60956)
8 subfertil$.tw. (4522)
9 Infertilit$.tw. (44291)
10 exp Sperm Injections, Intracytoplasmic/ or exp Reproductive Techniques/ or exp Reproductive Techniques, Assisted/ or exp Fertil-
ization in Vitro/ (137421)
11 (in vitro fertili$ or intracytoplasmic sperm).tw. (25251)
12 (IVF or ICSI).tw. (24282)
13 IUI.tw. (1544)
14 artificial insemination.tw. (5969)
15 (intrauter* adj2 inseminat*).tw. (2287)
16 assisted conception.tw. (1110)
17 assisted reproduct*.tw. (12595)
18 exp Myoma/ or exp Leiomyoma/ (21709)
19 (myoma or myomectomy).tw. (5800)
20 septoplast*.tw. (1522)
21 Asherman* syndrome.tw. (251)
22 metroplast*.tw. (363)
23 (sept* adj2 resect*).tw. (382)
24 septate uterus.tw. (392)
25 polypectomy.tw. (4158)
26 (remov$ adj2 polyp*).tw. (1326)
27 adhesiolysis.tw. (1346)
28 exp Tissue Adhesions/ (11844)
29 (?intrauter* adj2 adhesion$).tw. (445)
30 (remov$ adj4 adhesion$).tw. (414)
31 polyp$.tw. (254390)
32 uterine septa.tw. (92)
33 uterine septum.tw. (231)
34 synech*.tw. (9278)
35 Leiomyoma$.tw. (12730)
36 (uter$ adj2 malform$).tw. (775)
37 (Uter$ adj4 Neoplasm$).tw. (842)
38 (uter$ adj4 abnormalit$).tw. (1035)
39 fibroid$.tw. (5706)
40 or/7-39 (512038)
41 randomized controlled trial.pt. (458772)
42 controlled clinical trial.pt. (92329)
43 randomized.ab. (408806)
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44 placebo.tw. (193271)
45 clinical trials as topic.sh. (183298)
46 randomly.ab. (288659)
47 trial.ti. (180948)
48 (crossover or cross-over or cross over).tw. (76033)
49 or/41-48 (1172279)
50 exp animals/ not humans.sh. (4446637)
51 49 not 50 (1078473)
Appendix 4. Embase search strategy
Searched from 1980 to 16 April 2018
OVID Platform
1 exp hysteroscopy/ (10442)
2 Hysteroscop$.tw. (10344)
3 endoscop$.tw. (272107)
4 exp endoscopy/ or exp urogenital endoscopy/ (538246)
5 or/1-4 (654400)
6 exp female infertility/ or exp infertility therapy/ (117458)
7 subfertil$.tw. (6209)
8 Infertil$.tw. (73959)
9 artificial insemination/ or exp fertilization in vitro/ or exp intracytoplasmic sperm injection/ or exp intrauterine insemination/ (71950)
10 (in vitro fertili$ or intracytoplasmic sperm).tw. (32834)
11 (IVF or ICSI or IUI).tw. (43015)
12 artificial insemination.tw. (5647)
13 (intrauter* adj2 inseminat*).tw. (3417)
14 assisted conception.tw. (1601)
15 assisted reproduct*.tw. (19314)
16 or/6-15 (181531)
17 exp uterus myoma/ or exp myoma/ (34252)
18 exp leiomyoma/ (17459)
19 (myoma or myomectomy).tw. (8654)
20 septate uterus.tw. (626)
21 polypectomy.tw. (7240)
22 adhesiolysis.tw. (2445)
23 (remov$ adj2 adhesion$).tw. (253)
24 (?intrauter* adj2 adhesion$).tw. (679)
25 (septoplast* or metroplast*).tw. (2357)
26 (sept* adj2 resect*).tw. (560)
27 Asherman* syndrome.tw. (411)
28 polyp$.tw. (286769)
29 uterine septa.tw. (154)
30 uterine septum.tw. (469)
31 synech$.tw. (9682)
32 Leiomyoma$.tw. (15738)
33 (uter$ adj4 malform$).tw. (1402)
34 (Uter$ adj4 Neoplasm$).tw. (926)
35 (uter$ adj4 abnormalit$).tw. (1420)
36 fibroid$.tw. (9428)
37 or/17-36 (342555)
38 5 and 16 and 37 (2475)
39 Clinical Trial/ (964209)
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40 Randomized Controlled Trial/ (495134)
41 exp randomisation/ (77876)
42 Single Blind Procedure/ (31024)
43 Double Blind Procedure/ (145965)
44 Crossover Procedure/ (54970)
45 Placebo/ (309585)
46 Randomi?ed controlled trial$.tw. (179133)
47 Rct.tw. (28028)
48 random allocation.tw. (1767)
49 randomly allocated.tw. (29351)
50 allocated randomly.tw. (2307)
51 (allocated adj2 random).tw. (794)
52 Single blind$.tw. (20651)
53 Double blind$.tw. (181005)
54 ((treble or triple) adj blind$).tw. (765)
55 placebo$.tw. (266160)
56 prospective study/ (441083)
57 or/39-56 (1888652)
58 case study/ (53662)
59 case report.tw. (350881)
60 abstract report/ or letter/ (1032536)
61 or/58-60 (1428530)
Appendix 5. CINAHL search strategy
Searched from 1961 to 16 April 2018
EBSCO Platform
S43 S30 AND S42 184
S42 S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 1,224,457
S41 TX allocat* random* 8,624
S40 (MH “Quantitative Studies”) 19,276
S39 (MH “Placebos”) 10,763
S38 TX placebo* 50,564
S37 TX random* allocat* 8,624
S36 (MH “Random Assignment”) 46,918
S35 TX randomi* control* trial* 146,875
S34 TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or
(tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) 950,353
S33 TX clinic* n1 trial* 223,176
S32 PT Clinical trial 86,215
S31 (MH “Clinical Trials+”) 238,828
S30 S6 AND S29 1,027
S29 S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR
S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 24,606
S28 TX fibroid* 1,459
S27 TX (uter* N2 abnormalit*) 644
S26 TX (uter* N2 neoplasm*) 2,615
S25 TX (uter* malform*) 642
S24 TX Leiomyoma 3,066
S23 TX (uter* N4 polyp*)or TX (endometri* N4 poly*) 371
S22 TX(remov* N2 adhesion*) 28
S21 (MM “Adhesions”) 637
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S20 TX adhesiolysis 212
S19 TX (sept* uter*) 727
S18 TX (myoma or myomectomy) 1,107
S17 (MM “Leiomyoma”) 2,182
S16 (MM “Myoma+”) 184
S15 TX (assisted conception) 827
S14 TX (artificial insemination) 538
S13 (MM “Insemination, Artificial”) 277
S12 TX (IVF or ICSI) 2,283
S11 TX (Reproducti* Technique*) 5,749
S10 MH reproduction techniques 3,361
S9 (MM “Fertilization in Vitro”) 1,923
S8 TX subfertil* or TX infertil* 10,820
S7 (MM “Infertility”) 4,677
S6 S1 OR S2 OR S3 OR S4 OR S5 56,419
S5 (MM “Endoscopy”) 8,846
S4 TX endoscop* 55,025
S3 TX Uteroscop* 1
S2 TX Hysteroscop* 1,501
S1 (MM “Hysteroscopy”) 659
Appendix 6. Web of Science search strategy
Searched 16 April 2018
Web Platform
TOPIC: (((((Hysteroscopy OR Uterine Endoscop* OR Uteroscop* OR Hysteroscopic Surg* OR (hysteroscopic AND (polypectom*
OR myomectom* OR synechiolysis OR adhesiolysis OR metroplast* OR septoplast* OR septum resection*))) AND (female AND
(Subfertility OR Infertility OR Sterility)) AND ((Endometri* AND (polyp OR polyps)) OR Leiomyoma* OR Fibromyoma* OR
Fibroid* ORfibromas ORMyoma*ORSynechiaeOR ((Intrauterine ORuterine) ANDadhesion*) OR (Asherman* ANDSyndrome*)
OR ((septa OR septum) AND (uterine OR intrauterine)) OR uterine diseases OR uterine neoplasms OR ((uterine OR intrauterine)
AND (congenital abnormalities)) OR (Fertilization SAME “in Vitro”) OR IVF OR ICSI OR reproductive techniques OR embryo
transfer Or zygote intrafallopian transfer OR ((intrauterine OR artificial) AND insemination))))))
DocType=All document types; Language=All languages
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2014-2018
Appendix 7. Items of data extraction
1. Source
• Study ID
• Report ID
• Review author ID
• Citation and contact details
2. Eligibility
• Confirm eligibility for review
• Reason for exclusion
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3. Trial characteristics
• Study design
◦ Random sequence generation
◦ Participant recruitment
◦ Participant inclusion and exclusion criteria
◦ Allocation concealment
◦ Blinding of participants and personnel
◦ Blinding of outcome assessors
◦ Completeness of outcome data
◦ Selective outcome reporting
◦ Other potential sources of bias
• Follow-up
◦ Duration of follow-up
◦ Type of follow-up
• Size of study
◦ Number of women recruited
◦ Number of women randomised
◦ Number of women excluded
◦ Number of women withdrawn and lost to follow-up
◦ Number of women analysed
• Study setting
◦ Single-centre or multicentre
◦ Location
◦ Timing and duration
• Diagnostic criteria
◦ Screening by transvaginal ultrasound (TVS)
◦ Screening by hysterosalpingography (HSG)
◦ Screening by TVS and HSG
◦ Screening by other ultrasound diagnostic procedures, e.g. saline infusion sonography or gel instillation sonography
◦ Screening by hysteroscopy
◦ Diagnosis confirmed by hysteroscopy and biopsy
4. Characteristics of the study participants
• Baseline characteristics
◦ Age
◦ Primary or secondary subfertility
◦ Duration of subfertility
◦ Diagnostic work-up: baseline follicle stimulating hormone, semen analysis, diagnosis of tubal pathology, confirmatory test
of ovulation
◦ Other contributory causes to subfertility than uterine factor
◦ Previous treatments: in vitro fertilisation (IVF), intrauterine insemination (IUI) or other treatments
• 2. Treatment characteristics
◦ IUI natural cycle
◦ IUI controlled ovarian stimulation with antioestrogens or gonadotropins
◦ IVF protocol and number of embryos transferred
◦ Intracytoplasmic sperm injection protocol and number of embryos transferred
◦ Detailed description of the hysteroscopic procedure
5. Interventions
• Total number of intervention groups
• Absence of other interventions in the treatment and control group
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For each intervention and comparison group of interest
• Specific intervention
• Intervention details
• Timing of the intervention
6. Outcomes
• Outcomes and time points collected
• Outcomes and time points reported
Definition and unit of measurement for each of the following outcomes:
Primary outcomes
• Live birth delivery rate
• Hysteroscopy complication rate
Secondary outcomes
• Ongoing pregnancy rate
• Clinical pregnancy with foetal heartbeat
• Clinical pregnancy rate
• Miscarriage rate
For each outcome of interest:
• Sample size
• Missing participants
• Summary data for each intervention group in 2 × 2 table
• Estimate of effect with 95% confidence interval
• Subgroup analyses
7. Miscellaneous
• Funding source
• Key conclusions of the study authors
• Miscellaneous comments from the study authors
• References to other relevant studies
• Correspondence required
• Miscellaneous comments by the review authors
WH A T ’ S N E W
Date Event Description
20 June 2018 New citation required but conclusions have not changed The conclusions of this review have not changed
17 June 2018 New search has been performed Updated literature search from 1 January 2014 until 16
April 2018. No new studies included
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H I S T O R Y
Protocol first published: Issue 11, 2011
Review first published: Issue 1, 2013
Date Event Description
29 October 2014 New search has been performed This review has been updated but no new studies were
eligible for inclusion
29 October 2014 New citation required but conclusions have not
changed
There was no change to our conclusions.
29 August 2014 Feedback has been incorporated Feedback on clinical diversity in this review, received
from Professor Hossam Shawki
C O N T R I B U T I O N S O F A U T H O R S
JB: co-ordinated the writing of the protocol and review and its update.
SVW and MB: assisted in the literature search and study selection.
FB and TD: independently assessed the retrieved published reports for inclusion of potentially eligible studies.
JB and SW: independently extracted study data.
FB and BWM: gave advice on review methodology and content and critically appraised the Cochrane Review.
D E C L A R A T I O N S O F I N T E R E S T
FB (principal investigator) and BWM (co-investigator) were involved in the design and conduct of the ’inSIGHT trial’ (SIGnificance
of Routine Hysteroscopy Prior to a First ’in Vitro Fertilization’ Treatment Cycle: NCT 01242852), which was financially supported
by ZonMw, a Dutch government operated consortium responsible for granting funds in the field of clinical practice research.
Thomas D’Hooghe is paid full time by Merck KGaA, Darmstadt, Germany as Vice-President and Head of Global Medical Affairs
Fertility since October 1st 2015. He is also part time employed by KU Leuven (University of Leuven, Belgium) as Professor in
Reproductive Medicine and by Yale University as Adjunct Professor Obstetrics and Gynecology. His co-authorship on the current
paper is part of his academic activity, and Merck KGaA does not have marketed products related to hysteroscopy. Professor D’Hooghe’s
employment by Merck is not in breach of Cochrane’s Commercial Sponsorship Policy (clause 2) as he does not have a real or potential
financial interest in the outcome of this review. This matter was referred to Cochrane’s Funding Arbiter for advice.
FB has received monetary compensation for the following: member of the external advisory board for Merck Serono and Ferring,
the Netherlands; educational activities for Ferring BV, the Netherlands; consultancy work for Gedeon Richter, Belgium; strategic co-
operation with Roche on automated anti-Müllerian hormone (AMH) assay development; and research co-operation with Ansh Labs.
BWM has received consultancy from ObsEva Geneva, Guerbet, and Merck; payment for review preparation from European Journal
of Obstetrics and Gynecology and Reproductive Biology; and travel/accommodation/meeting expenses for various non-commercial
scientific meetings.
JB, SW, SVW and MB do not have conflicts of interest for the research presented in this updated Cochrane Review.
The first published version of the present Cochrane Review has been part of a PhD thesis entitled “Studies on the effectiveness of
endoscopic surgery in reproductive medicine” ( dare.uva.nl/record/497164), which has been successfully defended at the faculty of
Medicine of the University of Amsterdam, the Netherlands on 2 September 2014 by the first author (JB).
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S O U R C E S O F S U P P O R T
Internal sources
• CEBAM, Belgium.
Research grant was obtained through CEBAM, the Centre for Evidence-based Medicine, Belgian Branch of Cochrane
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
At the 2014 update:
• As a result of further peer review, the objectives of the review have been rephrased. The descriptions in the Types of interventions
and Data synthesis sections were modified accordingly. For both comparisons, we made a stratification according to the types of
uterine pathology; for the second comparison, we made a clear distinction between IUI, IVF or ICSI.
• ’Summary of findings’ tables using the GRADE approach were added.
• In the Assessment of risk of bias in included studies section of the review, the items ’blinding of participants and personnel’ and
’blinding of outcome assessors’ were reinserted as requested by the editorial reviewers. We assessed all six items including blinding of
participants, personnel and outcome assessors in the final review as opposed to the protocol.
• In the Assessment of heterogeneity section of the review, we added the Q-statistic.
• In the Subgroup analysis and investigation of heterogeneity section of the review, we planned to conduct a further subgroup
analysis based on the women’s age.
At the 2018 update:
• We added a fourth exclusion criterion in the section Types of participants: women of reproductive age with no major uterine
cavity abnormalities detected by US, SIS, GIS, HSG, diagnostic hysteroscopy or any combination of these methods. The objective of
this review was to assess the effectiveness of operative hysteroscopy in women with suspected uterine cavity abnormalities. The
effectiveness of hysteroscopy in women without suspected uterine cavity abnormalities is the objective of a second Cochrane review.
The addition of this fourth exclusion criterion is to emphasise the difference between the reviews since they include different study
populations.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Hysteroscopy; Coitus; Endometrium; Fertilization inVitro; Infertility [etiology; ∗surgery]; Insemination, Artificial [methods]; Leiomy-
oma [surgery]; Polyps [surgery]; Randomized Controlled Trials as Topic; Tissue Adhesions [surgery]; Uterine Diseases [∗surgery];
Uterus [abnormalities]
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MeSH check words
Female; Humans; Pregnancy
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